{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 15965, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:52Z", "timestamp": 1574489032910}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "S4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1998, 1, 1]], "date-time": "1998-01-01T00:00:00Z", "timestamp": 883612800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1998, 1]]}, "DOI": "10.1038/bjc.1998.430", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:52:58Z", "timestamp": 1295005978000}, "page": "12-14", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine"], "prefix": "10.1038", "volume": "77", "author": [{"given": "JM", "family": "Brown", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1998430.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1998430", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1998430.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T05:25:05Z", "timestamp": 1552713905000}, "score": 50.140495, "issued": {"date-parts": [[1998, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 1]]}, "issue": "S4"}, "alternative-id": ["BFbjc1998430"], "URL": "http://dx.doi.org/10.1038/bjc.1998.430", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T11:03:36Z", "timestamp": 1576667016109}, "reference-count": 140, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 6, 1]], "date-time": "2004-06-01T00:00:00Z", "timestamp": 1086048000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Nat Rev Cancer"], "published-print": {"date-parts": [[2004, 6]]}, "DOI": "10.1038/nrc1367", "type": "journal-article", "created": {"date-parts": [[2004, 6, 1]], "date-time": "2004-06-01T10:01:59Z", "timestamp": 1086084119000}, "page": "437-447", "source": "Crossref", "is-referenced-by-count": 1242, "title": ["Exploiting tumour hypoxia in cancer treatment"], "prefix": "10.1038", "volume": "4", "author": [{"given": "J. Martin", "family": "Brown", "sequence": "first", "affiliation": []}, {"given": "William R.", "family": "Wilson", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "BFnrc1367_CR1", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1038/bjc.1955.55", "volume": "9", "author": "RH Thomlinson", "year": "1955", "unstructured": "Thomlinson, R. H. & Gray, L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9, 539\u2013549 (1955).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1367_CR2", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1259/0007-1285-26-312-638", "volume": "26", "author": "LH Gray", "year": "1953", "unstructured": "Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S. & Scott, O. C. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26, 638\u2013648 (1953). References 1 and 2 are classic papers describing both the general nature of the oxygen effect in reducing radiation sensitivity (reference 2) and the fact that the hypoxic cells almost certainly are present in human tumours (reference 1).", "journal-title": "Br. J. Radiol."}, {"key": "BFnrc1367_CR3", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1016/0360-3016(84)90063-4", "volume": "10", "author": "JM Brown", "year": "1984", "unstructured": "Brown, J. M. Clinical trials of radiosensitizers: what should we expect? Int. J. Radiat. Oncol. Biol. Phys. 10, 425\u2013429 (1984).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR4", "first-page": "509", "volume": "6", "author": "J Overgaard", "year": "1994", "unstructured": "Overgaard, J. Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol. Res. 6, 509\u2013518 (1994).", "journal-title": "Oncol. Res."}, {"key": "BFnrc1367_CR5", "first-page": "3316", "volume": "51", "author": "P Vaupel", "year": "1991", "unstructured": "Vaupel, P., Schlenger, K., Knoop, C. & Hockel, M. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res. 51, 3316\u20133322 (1991).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR6", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1016/S0167-8140(96)91811-3", "volume": "41", "author": "M Nordsmark", "year": "1996", "unstructured": "Nordsmark, M., Overgaard, M. & Overgaard, J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41, 31\u201340 (1996).", "journal-title": "Radiother. Oncol."}, {"key": "BFnrc1367_CR7", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1016/S0167-8140(99)00102-4", "volume": "53", "author": "DM Brizel", "year": "1999", "unstructured": "Brizel, D. M., Dodge, R. K., Clough, R. W. & Dewhirst, M. W. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother. Oncol. 53, 113\u2013117 (1999).", "journal-title": "Radiother. Oncol."}, {"issue": "Suppl. 2", "key": "BFnrc1367_CR8", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0140-6736(98)90327-0", "volume": "351", "author": "IF Tannock", "year": "1998", "unstructured": "Tannock, I. F. Conventional cancer therapy: promise broken or promise delayed? Lancet 351 (Suppl. 2), 9\u201316 (1998).", "journal-title": "Lancet"}, {"key": "BFnrc1367_CR9", "first-page": "691", "volume": "8", "author": "RE Durand", "year": "1994", "unstructured": "Durand, R. E. The influence of microenvironmental factors during cancer therapy. In vivo 8, 691\u2013702 (1994).", "journal-title": "In vivo"}, {"key": "BFnrc1367_CR10", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.1038/bjc.1968.34", "volume": "22", "author": "IF Tannock", "year": "1968", "unstructured": "Tannock, I. F. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br. J. Cancer 22, 258\u2013273 (1968).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1367_CR11", "first-page": "73", "volume": "41", "author": "BA Teicher", "year": "1981", "unstructured": "Teicher, B. A., Lazo, J. S. & Sartorelli, A. C. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res. 41, 73\u201381 (1981).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR12", "first-page": "S52", "volume": "27", "author": "RM Batchelder", "year": "1996", "unstructured": "Batchelder, R. M., Wilson, W. R., Hay, M. P. & Denny, W. A. Oxygen dependence of the cytotoxicity of the enediyne anti-tumour antibiotic esperamicin A1. Br. J. Cancer Suppl. 27, S52\u2013S56 (1996).", "journal-title": "Br. J. Cancer Suppl."}, {"key": "BFnrc1367_CR13", "first-page": "3387", "volume": "62", "author": "KM Comerford", "year": "2002", "unstructured": "Comerford, K. M. et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387\u20133394 (2002).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR14", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1096/fj.02-0358fje", "volume": "17", "author": "M Wartenberg", "year": "2003", "unstructured": "Wartenberg, M. et al. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J. 17, 503\u2013505 (2003).", "journal-title": "FASEB J."}, {"key": "BFnrc1367_CR15", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1038/379088a0", "volume": "379", "author": "TG Graeber", "year": "1996", "unstructured": "Graeber, T. G. et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88\u201391 (1996). Describes how hypoxia in tumours selects against wild-type p53 by causing apoptosis in these cells.", "journal-title": "Nature"}, {"key": "BFnrc1367_CR16", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/S0027-5107(98)00042-6", "volume": "400", "author": "J Yuan", "year": "1998", "unstructured": "Yuan, J. & Glazer, P. M. Mutagenesis induced by the tumor microenvironment. Mutat. Res. 400, 439\u2013446 (1998).", "journal-title": "Mutat. Res."}, {"key": "BFnrc1367_CR17", "doi-asserted-by": "crossref", "first-page": "38", "DOI": "10.1038/nrc704", "volume": "2", "author": "AL Harris", "year": "2002", "unstructured": "Harris, A. L. Hypoxia \u2014 a key regulatory factor in tumour growth. Nature Rev. Cancer 2, 38\u201347 (2002).", "journal-title": "Nature Rev. Cancer"}, {"key": "BFnrc1367_CR18", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1016/S1535-6108(03)00085-0", "volume": "3", "author": "S Pennacchietti", "year": "2003", "unstructured": "Pennacchietti, S. et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347\u2013361 (2003).", "journal-title": "Cancer Cell"}, {"key": "BFnrc1367_CR19", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1080/095530000138259", "volume": "76", "author": "EK Rofstad", "year": "2000", "unstructured": "Rofstad, E. K. Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol. 76, 589\u2013605 (2000).", "journal-title": "Int. J. Radiat. Biol."}, {"key": "BFnrc1367_CR20", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1023/A:1022939318102", "volume": "20", "author": "P Subarsky", "year": "2003", "unstructured": "Subarsky, P. & Hill, R. P. The hypoxic tumour microenvironment and metastatic progression. Clin. Exp. Metastasis 20, 237\u2013250 (2003).", "journal-title": "Clin. Exp. Metastasis"}, {"key": "BFnrc1367_CR21", "first-page": "4509", "volume": "56", "author": "M Hockel", "year": "1996", "unstructured": "Hockel, M. et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56, 4509\u20134515 (1996).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR22", "first-page": "941", "volume": "56", "author": "DM Brizel", "year": "1996", "unstructured": "Brizel, D. M. et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941\u2013943 (1996).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR23", "doi-asserted-by": "crossref", "first-page": "1239", "DOI": "10.1016/0360-3016(86)90267-1", "volume": "12", "author": "EM Zeman", "year": "1986", "unstructured": "Zeman, E. M., Brown, J. M., Lemmon, M. J., Hirst, V. K. & Lee, W. W. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int. J. Radiat. Oncol. Biol. Phys. 12, 1239\u20131242 (1986). The initial paper describing the hypoxic selectivity of tirapazamine for cell killing.", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR24", "first-page": "7745", "volume": "50", "author": "JM Brown", "year": "1990", "unstructured": "Brown, J. M. & Lemmon, M. J. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors. Cancer Res. 50, 7745\u20137749 (1990).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR25", "doi-asserted-by": "crossref", "first-page": "1163", "DOI": "10.1038/bjc.1993.220", "volume": "67", "author": "JM Brown", "year": "1993", "unstructured": "Brown, J. M. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br. J. Cancer 67, 1163\u20131170 (1993).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1367_CR26", "doi-asserted-by": "crossref", "first-page": "3380", "DOI": "10.1021/ja9510774", "volume": "118", "author": "JS Daniels", "year": "1996", "unstructured": "Daniels, J. S. & Gates, K. S. DNA cleavage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (SR4233): Evidence for involvement of hydroxyl radical. J. Am. Chem. Soc. 118, 3380\u20133385 (1996).", "journal-title": "J. Am. Chem. Soc."}, {"key": "BFnrc1367_CR27", "doi-asserted-by": "crossref", "first-page": "881", "DOI": "10.1016/S1044-0305(03)00334-9", "volume": "14", "author": "D Zagorevskii", "year": "2003", "unstructured": "Zagorevskii, D. et al. A mass spectrometry study of tirapazamine and its metabolites. insights into the mechanism of metabolic transformations and the characterization of reaction intermediates. J. Am. Soc. Mass Spectrom. 14, 881\u2013892 (2003).", "journal-title": "J. Am. Soc. Mass Spectrom."}, {"key": "BFnrc1367_CR28", "doi-asserted-by": "crossref", "first-page": "748", "DOI": "10.1021/ja0209363", "volume": "125", "author": "RF Anderson", "year": "2003", "unstructured": "Anderson, R. F., Shinde, S. S., Hay, M. P., Gamage, S. A. & Denny, W. A. Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction. J. Am. Chem. Soc. 125, 748\u2013756 (2003).", "journal-title": "J. Am. Chem. Soc."}, {"key": "BFnrc1367_CR29", "first-page": "5248", "volume": "62", "author": "KB Peters", "year": "2002", "unstructured": "Peters, K. B. & Brown, J. M. Tirapazamine: a hypoxia-activated topoisomerase II poison. Cancer Res. 62, 5248\u20135253 (2002).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR30", "first-page": "4633", "volume": "53", "author": "MJ Dorie", "year": "1993", "unstructured": "Dorie, M. J. & Brown, J. M. Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin. Cancer Res. 53, 4633\u20134636 (1993). In vivo  data showing that tirapazamine and cisplatin have a marked hypoxia and schedule-dependent synergism.", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR31", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1038/sj.bjc.6690492", "volume": "80", "author": "MS Kovacs", "year": "1999", "unstructured": "Kovacs, M. S. et al. Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin. Br. J Cancer 80, 1245\u20131251 (1999).", "journal-title": "Br. J Cancer"}, {"key": "BFnrc1367_CR32", "doi-asserted-by": "crossref", "first-page": "1351", "DOI": "10.1200/JCO.2000.18.6.1351", "volume": "18", "author": "J von Pawel", "year": "2000", "unstructured": "von Pawel, J. et al. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. J. Clin. Oncol. 18, 1351\u20131359 (2000). Clinical data showing the efficacy of tirapazamine in combination with cisplatin in a randomized multicentre Phase III trial.", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1367_CR33", "first-page": "A1992", "volume": "22", "author": "D Rischin", "year": "2003", "unstructured": "Rischin, D. et al. Preliminary results of TROG 98.02\u2014a randomized phase II study of 5-fluorouracil, cisplatin and radiation versus tirapazamine, cisplatin and radiation for advanced squamous cell carcinoma of the head and neck. Proc. Am. Soc. Clin. Oncol. 22, A1992 (2003).", "journal-title": "Proc. Am. Soc. Clin. Oncol."}, {"key": "BFnrc1367_CR34", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1007/BF00689805", "volume": "12", "author": "LH Patterson", "year": "1993", "unstructured": "Patterson, L. H. Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent. Cancer Metastasis Rev. 12, 119\u2013134 (1993).", "journal-title": "Cancer Metastasis Rev."}, {"key": "BFnrc1367_CR35", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1081/DMR-120005659", "volume": "34", "author": "LH Patterson", "year": "2002", "unstructured": "Patterson, L. H. Bioreductively activated antitumor N-oxides: the case of AQ4N, a unique approach to hypoxia-activated cancer chemotherapy. Drug Metab. Rev. 34, 581\u2013592 (2002).", "journal-title": "Drug Metab. Rev."}, {"key": "BFnrc1367_CR36", "doi-asserted-by": "crossref", "first-page": "1335", "DOI": "10.2174/1381612023394502", "volume": "8", "author": "LH Patterson", "year": "2002", "unstructured": "Patterson, L. H. & Murray, G. I. Tumour cytochrome P450 and drug activation. Curr. Pharm. Des. 8, 1335\u20131347 (2002).", "journal-title": "Curr. Pharm. Des."}, {"key": "BFnrc1367_CR37", "doi-asserted-by": "crossref", "first-page": "1589", "DOI": "10.1054/bjoc.2000.1564", "volume": "83", "author": "LH Patterson", "year": "2000", "unstructured": "Patterson, L. H. & McKeown, S. R. AQ4N: a new approach to hypoxia-activated cancer chemotherapy. Br. J. Cancer 83, 1589\u20131593 (2000).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1367_CR38", "doi-asserted-by": "crossref", "first-page": "1984", "DOI": "10.1054/bjoc.2000.1163", "volume": "82", "author": "LH Patterson", "year": "2000", "unstructured": "Patterson, L. H. et al. Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent. Br. J. Cancer 82, 1984\u20131990 (2000). Demonstration of potentiation of radiation and chemotherapy by the bioreductive agent AQ4N.", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1367_CR39", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1016/0360-3016(94)90267-4", "volume": "29", "author": "GE Adams", "year": "1994", "unstructured": "Adams, G. E. & Stratford, I. J. Bioreductive drugs for cancer therapy: the search for tumor specificity. Int. J. Radiat. Oncol. Biol. Phys. 29, 231\u2013238 (1994).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR40", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1016/S1053-4296(96)80033-6", "volume": "6", "author": "JM Brown", "year": "1996", "unstructured": "Brown, J. M. & Siim, B. G. Hypoxia-specific cytotoxins in cancer therapy. Semin. Rad. Onc. 6, 22\u201336 (1996).", "journal-title": "Semin. Rad. Onc."}, {"key": "BFnrc1367_CR41", "doi-asserted-by": "crossref", "first-page": "1093", "DOI": "10.2174/0929867013372634", "volume": "8", "author": "FM de Groot", "year": "2001", "unstructured": "de Groot, F. M., Damen, E. W. & Scheeren, H. W. Anticancer prodrugs for application in monotherapy: targeting hypoxia, tumor-associated enzymes, and receptors. Curr. Med. Chem. 8, 1093\u20131122 (2001).", "journal-title": "Curr. Med. Chem."}, {"key": "BFnrc1367_CR42", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1007/BF00689806", "volume": "12", "author": "WA Denny", "year": "1993", "unstructured": "Denny, W. A. & Wilson, W. R. Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs). Cancer Metastasis Rev. 12, 135\u2013151 (1993).", "journal-title": "Cancer Metastasis Rev."}, {"key": "BFnrc1367_CR43", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.2174/1389557013407241", "volume": "1", "author": "MA Naylor", "year": "2001", "unstructured": "Naylor, M. A. & Thomson, P. Recent advances in bioreductive drug targeting. Mini Rev. Med. Chem. 1, 17\u201329 (2001).", "journal-title": "Mini Rev. Med. Chem."}, {"key": "BFnrc1367_CR44", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1016/S0360-3016(98)00302-2", "volume": "42", "author": "AM Rauth", "year": "1998", "unstructured": "Rauth, A. M., Melo, T. & Misra, V. Bioreductive therapies: an overview of drugs and their mechanisms of action. Int. J. Radiat. Oncol. Biol. Phys. 42, 755\u2013762 (1998).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR45", "first-page": "29", "volume": "19", "author": "S Rockwell", "year": "1992", "unstructured": "Rockwell, S. Use of hypoxia-directed drugs in the therapy of solid tumors. Semin. Oncol. 19, 29\u201340 (1992).", "journal-title": "Semin. Oncol."}, {"key": "BFnrc1367_CR46", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1007/BF00689802", "volume": "12", "author": "P Workman", "year": "1993", "unstructured": "Workman, P. & Stratford, I. J. The experimental development of bioreductive drugs and their role in cancer therapy. Cancer Metastasis Rev. 12, 73\u201382 (1993).", "journal-title": "Cancer Metastasis Rev."}, {"key": "BFnrc1367_CR47", "first-page": "5714", "volume": "9", "author": "MV Papadopoulou", "year": "2003", "unstructured": "Papadopoulou, M. V. & Bloomer, W. D. NLCQ-1 (NSC 709257): exploiting hypoxia with a weak DNA-intercalating bioreductive drug. Clin. Cancer Res. 9, 5714\u20135720 (2003).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrc1367_CR48", "first-page": "1088", "volume": "297", "author": "KO Hicks", "year": "2001", "unstructured": "Hicks, K. O., Pruijn, F. B., Baguley, B. C. & Wilson, W. R. Extravascular transport of the DNA intercalator and topoisomerase poison N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA): diffusion and metabolism in multicellular layers of tumor cells. J. Pharmacol. Exp. Ther. 297, 1088\u20131098 (2001).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BFnrc1367_CR49", "doi-asserted-by": "crossref", "first-page": "1807", "DOI": "10.1016/S0006-2952(03)00199-0", "volume": "65", "author": "YM Delahoussaye", "year": "2003", "unstructured": "Delahoussaye, Y. M., Hay, M. P., Pruijn, F. B., Denny, W. A. & Brown, J. M. Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting. Biochem. Pharmacol. 65, 1807\u20131815 (2003).", "journal-title": "Biochem. Pharmacol."}, {"key": "BFnrc1367_CR50", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1021/jm030399c", "volume": "47", "author": "MP Hay", "year": "2004", "unstructured": "Hay, M. P. et al. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides as hypoxia\u2013selective analogues of tirapazamine. J. Med. Chem. 47, 475\u2013488 (2004).", "journal-title": "J. Med. Chem."}, {"key": "BFnrc1367_CR51", "first-page": "S32", "volume": "27", "author": "WA Denny", "year": "1996", "unstructured": "Denny, W. A., Wilson, W. R. & Hay, M. P. Recent developments in the design of bioreductive drugs. Br. J. Cancer Suppl. 27, S32\u2013S38 (1996).", "journal-title": "Br. J. Cancer Suppl."}, {"key": "BFnrc1367_CR52", "first-page": "3992", "volume": "53", "author": "CJ Koch", "year": "1993", "unstructured": "Koch, C. J. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin. Cancer Res. 53, 3992\u20133997 (1993).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR53", "unstructured": "Hicks, K. O., Siim, B. G., Pruijn, F. B. & Wilson, W. R. Oxygen dependence of the metabolic activation and cytotoxicity of tirapazamine: Implications for exptravascular transport and activity in tumors. Radiat. Res. (in the press).", "DOI": "10.1667/RR3178", "doi-asserted-by": "crossref"}, {"key": "BFnrc1367_CR54", "first-page": "5655", "volume": "48", "author": "RS Marshall", "year": "1988", "unstructured": "Marshall, R. S. & Rauth, A. M. Oxygen and exposure kinetics as factors influencing the cytotoxicity of porfiromycin, a mitomycin C analogue, in Chinese hamster ovary cells. Cancer Res. 48, 5655\u20135659 (1988).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR55", "doi-asserted-by": "crossref", "first-page": "596", "DOI": "10.1038/bjc.1994.357", "volume": "70", "author": "BG Siim", "year": "1994", "unstructured": "Siim, B. G., Atwell, G. J. & Wilson, W. R. Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs. Br. J. Cancer 70, 596\u2013603 (1994).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1367_CR56", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1016/0360-3016(94)90283-6", "volume": "29", "author": "WR Wilson", "year": "1994", "unstructured": "Wilson, W. R., Moselen, J. W., Cliffe, S., Denny, W. A. & Ware, D. C. Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771. Int. J. Radiat. Oncol. Biol. Phys. 29, 323\u2013327 (1994).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR57", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.2307/3579620", "volume": "147", "author": "BG Wouters", "year": "1997", "unstructured": "Wouters, B. G. & Brown, J. M. Cells at intermediate oxygen levels can be more important than the 'hypoxic fraction' in determining tumor response to fractionated radiotherapy. Radiat. Res. 147, 541\u2013550 (1997).", "journal-title": "Radiat. Res."}, {"key": "BFnrc1367_CR58", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1006/taap.1999.8834", "volume": "163", "author": "AE Lee", "year": "2000", "unstructured": "Lee, A. E. & Wilson, W. R. Hypoxia-dependent retinal toxicity of bioreductive anticancer prodrugs in mice. Toxicol. Appl. Pharmacol. 163, 50\u201359 (2000).", "journal-title": "Toxicol. Appl. Pharmacol."}, {"key": "BFnrc1367_CR59", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/0360-3016(83)90104-9", "volume": "9", "author": "MJ Allalunis", "year": "1983", "unstructured": "Allalunis, M. J., Chapman, J. D. & Turner, A. R. Identification of a hypoxic population of bone marrow cells. Int. J. Radiat. Oncol. Biol. Phys. 9, 227\u2013232 (1983).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR60", "first-page": "2031", "volume": "82", "author": "MG Cipolleschi", "year": "1993", "unstructured": "Cipolleschi, M. G., Dello Sbarba, P. & Olivotto, M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82, 2031\u20132037 (1993).", "journal-title": "Blood"}, {"key": "BFnrc1367_CR61", "first-page": "357", "volume": "9", "author": "BG Siim", "year": "1997", "unstructured": "Siim, B. G., Denny, W. A. & Wilson, W. R. Nitro reduction as an electronic switch for bioreductive drug activation. Oncol. Res. 9, 357\u2013369 (1997).", "journal-title": "Oncol. Res."}, {"key": "BFnrc1367_CR62", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1021/tx025662b", "volume": "16", "author": "NA Helsby", "year": "2003", "unstructured": "Helsby, N. A. et al. Effect of nitroreduction on the alkylating reactivity and cytotoxicity of the 2,4-dinitrobenzamide-5-aziridine CB 1954 and the corresponding nitrogen mustard SN 23862: distinct mechanisms of bioreductive activation. Chem. Res. Toxicol. 16, 469\u2013478 (2003).", "journal-title": "Chem. Res. Toxicol."}, {"key": "BFnrc1367_CR63", "first-page": "1425", "volume": "62", "author": "WR Wilson", "year": "2002", "unstructured": "Wilson, W. R. et al. Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures. Cancer Res. 62, 1425\u20131432 (2002). Demonstrates the use of three-dimensional cell cultures to show bystander effects from GDEPT.", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR64", "doi-asserted-by": "crossref", "first-page": "2258", "DOI": "10.1021/jm0001020", "volume": "43", "author": "RF Borch", "year": "2000", "unstructured": "Borch, R. F. et al. Synthesis and evaluation of nitroheterocyclic phosphoramidates as hypoxia-selective alkylating agents. J. Med. Chem. 43, 2258\u20132265 (2000).", "journal-title": "J. Med. Chem."}, {"key": "BFnrc1367_CR65", "doi-asserted-by": "crossref", "first-page": "3511", "DOI": "10.1021/jm010202l", "volume": "44", "author": "M Tercel", "year": "2001", "unstructured": "Tercel, M. et al. Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine. J. Med. Chem. 44, 3511\u20133522 (2001).", "journal-title": "J. Med. Chem."}, {"key": "BFnrc1367_CR66", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1016/0360-3016(94)90283-6", "volume": "29", "author": "WR Wilson", "year": "1994", "unstructured": "Wilson, W. R., Moselen, J. W., Cliffe, S., Denny, W. A. & Ware, D. C. Exploiting tumor hypoxia through bioreductive release of diffusible cytotoxins: the cobalt(III)-nitrogen mustard complex SN 24771. Int. J. Radiat. Oncol. Biol. Phys. 29, 323\u2013327 (1994).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR67", "doi-asserted-by": "crossref", "first-page": "1629", "DOI": "10.1016/S0006-2952(02)00885-7", "volume": "63", "author": "SA Everett", "year": "2002", "unstructured": "Everett, S. A. et al. Modifying rates of reductive elimination of leaving groups from indolequinone prodrugs: a key factor in controlling hypoxia-selective drug release. Biochem. Pharmacol. 63, 1629\u20131639 (2002).", "journal-title": "Biochem. Pharmacol."}, {"key": "BFnrc1367_CR68", "first-page": "663", "volume": "13", "author": "WR Wilson", "year": "1998", "unstructured": "Wilson, W. R., Tercel, M., Anderson, R. F. & Denny, W. A. Radiation-activated prodrugs as hypoxia-selective cytotoxins: model studies with nitroarylmethyl quaternary salts. Anticancer Drug Des. 13, 663\u2013685 (1998).", "journal-title": "Anticancer Drug Des."}, {"key": "BFnrc1367_CR69", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1667/0033-7587(2002)158[0753:PORFOH]2.0.CO;2", "volume": "158", "author": "AG Kriste", "year": "2002", "unstructured": "Kriste, A. G., Tercel, M., Anderson, R. F., Ferry, D. M. & Wilson, W. R. Pathways of reductive fragmentation of heterocyclic nitroarylmethyl quaternary ammonium prodrugs of mechlorethamine. Radiat. Res. 158, 753\u2013762 (2002).", "journal-title": "Radiat. Res."}, {"key": "BFnrc1367_CR70", "unstructured": "Ahn, G., Ware, D. C., Denny, W. A. & Wilson, W. R. Optimization of the auxiliary ligand shell of cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation\u2013activated prodrugs. Radiat. Res. (in the press).", "DOI": "10.1667/RR3229", "doi-asserted-by": "crossref"}, {"key": "BFnrc1367_CR71", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1111/j.1349-7006.2000.tb00963.x", "volume": "91", "author": "Y Shibamoto", "year": "2000", "unstructured": "Shibamoto, Y., Zhou, L., Hatta, H., Mori, M. & Nishimoto, S. A novel class of antitumor prodrug, 1-(2\u2032-oxopropyl)-5-fluorouracil (OFU001), that releases 5-fluorouracil upon hypoxic irradiation. Jpn J. Cancer Res. 91, 433\u2013438 (2000).", "journal-title": "Jpn J. Cancer Res."}, {"key": "BFnrc1367_CR72", "first-page": "5830", "volume": "59", "author": "H Zhong", "year": "1999", "unstructured": "Zhong, H. et al. Overexpression of hypoxia-inducible factor 1\u03b1 in common human cancers and their metastases. Cancer Res. 59, 5830\u20135835 (1999).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR73", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1016/S0002-9440(10)64554-3", "volume": "157", "author": "KL Talks", "year": "2000", "unstructured": "Talks, K. L. et al. The expression and distribution of the hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157, 411\u2013421 (2000).", "journal-title": "Am. J. Pathol."}, {"key": "BFnrc1367_CR74", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1016/S0360-3016(98)00298-3", "volume": "42", "author": "T Shibata", "year": "1998", "unstructured": "Shibata, T., Akiyama, N., Noda, M., Sasai, K. & Hiraoka, M. Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes. Int. J. Radiat. Oncol. Biol. Phys. 42, 913\u2013916 (1998).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR75", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H", "volume": "187", "author": "O Greco", "year": "2001", "unstructured": "Greco, O. & Dachs, G. U. Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives. J. Cell Physiol. 187, 22\u201336 (2001).", "journal-title": "J. Cell Physiol."}, {"key": "BFnrc1367_CR76", "doi-asserted-by": "crossref", "first-page": "540", "DOI": "10.1038/sj.gt.3301944", "volume": "10", "author": "K Binley", "year": "2003", "unstructured": "Binley, K. et al. Hypoxia-mediated tumour targeting. Gene Ther. 10, 540\u2013549 (2003).", "journal-title": "Gene Ther."}, {"key": "BFnrc1367_CR77", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1038/sj.neo.7900189", "volume": "4", "author": "T Shibata", "year": "2002", "unstructured": "Shibata, T., Giaccia, A. J. & Brown, J. M. Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy. Neoplasia 4, 40\u201348 (2002).", "journal-title": "Neoplasia"}, {"key": "BFnrc1367_CR78", "doi-asserted-by": "crossref", "first-page": "946", "DOI": "10.1038/sj.gt.3301702", "volume": "9", "author": "AV Patterson", "year": "2002", "unstructured": "Patterson, A. V. et al. Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours. Gene Ther. 9, 946\u2013954 (2002).", "journal-title": "Gene Ther."}, {"key": "BFnrc1367_CR79", "first-page": "4808", "volume": "55", "author": "QT Trinh", "year": "1995", "unstructured": "Trinh, Q. T., Austin, E. A., Murray, D. M., Knick, V. C. & Huber, B. E. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5- fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res. 55, 4808\u20134812 (1995).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR80", "doi-asserted-by": "crossref", "first-page": "40", "DOI": "10.1038/sj.cgt.7700522", "volume": "10", "author": "HO McCarthy", "year": "2003", "unstructured": "McCarthy, H. O. et al. Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N. Cancer Gene Ther. 10, 40\u201348 (2003).", "journal-title": "Cancer Gene Ther."}, {"key": "BFnrc1367_CR81", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1038/sj.gt.3301058", "volume": "7", "author": "L Griffiths", "year": "2000", "unstructured": "Griffiths, L. et al. The macrophage: a novel system to deliver gene therapy to pathological hypoxia. Gene Ther. 7, 255\u2013262 (2000).", "journal-title": "Gene Ther."}, {"key": "BFnrc1367_CR82", "doi-asserted-by": "crossref", "first-page": "204", "DOI": "10.1002/path.1029", "volume": "196", "author": "B Burke", "year": "2002", "unstructured": "Burke, B. et al. Expression of HIF-1\u03b1 by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. J. Pathol. 196, 204\u2013212 (2002).", "journal-title": "J. Pathol."}, {"key": "BFnrc1367_CR83", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1038/nrc1187", "volume": "3", "author": "GL Semenza", "year": "2003", "unstructured": "Semenza, G. L. Targeting HIF-1 for cancer therapy. Nature Rev. Cancer 3, 721\u2013732 (2003).", "journal-title": "Nature Rev. Cancer"}, {"key": "BFnrc1367_CR84", "doi-asserted-by": "crossref", "first-page": "803", "DOI": "10.1038/nrd1199", "volume": "2", "author": "A Giaccia", "year": "2003", "unstructured": "Giaccia, A., Siim, B. G. & Johnson, R. S. HIF-1 as a target for drug development. Nature Rev. Drug Discov. 2, 803\u2013811 (2003).", "journal-title": "Nature Rev. Drug Discov."}, {"key": "BFnrc1367_CR85", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.2169/internalmedicine.41.79", "volume": "41", "author": "GL Semenza", "year": "2002", "unstructured": "Semenza, G. L. Involvement of hypoxia-inducible factor 1 in human cancer. Intern. Med. 41, 79\u201383 (2002).", "journal-title": "Intern. Med."}, {"key": "BFnrc1367_CR86", "doi-asserted-by": "crossref", "first-page": "1335", "DOI": "10.1038/82146", "volume": "6", "author": "AL Kung", "year": "2000", "unstructured": "Kung, A. L., Wang, S., Klco, J. M., Kaelin, W. G. & Livingston, D. M. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nature Med. 6, 1335\u20131340 (2000).", "journal-title": "Nature Med."}, {"key": "BFnrc1367_CR87", "first-page": "4316", "volume": "62", "author": "A Rapisarda", "year": "2002", "unstructured": "Rapisarda, A. et al. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62, 4316\u20134324 (2002).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR88", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1038/sj.gt.3301388", "volume": "8", "author": "X Sun", "year": "2001", "unstructured": "Sun, X. et al. Gene transfer of antisense hypoxia inducible factor-1\u03b1 enhances the therapeutic efficacy of cancer immunotherapy. Gene Ther. 8, 638\u2013645 (2001).", "journal-title": "Gene Ther."}, {"key": "BFnrc1367_CR89", "first-page": "2478", "volume": "62", "author": "NJ Mabjeesh", "year": "2002", "unstructured": "Mabjeesh, N. J. et al. Geldanamycin induces degradation of hypoxia-inducible factor 1\u03b1 protein via the proteosome pathway in prostate cancer cells. Cancer Res. 62, 2478\u20132482 (2002).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR90", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1016/S1535-6108(03)00077-1", "volume": "3", "author": "NJ Mabjeesh", "year": "2003", "unstructured": "Mabjeesh, N. J. et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3, 363\u2013375 (2003).", "journal-title": "Cancer Cell"}, {"key": "BFnrc1367_CR91", "doi-asserted-by": "crossref", "first-page": "516", "DOI": "10.1093/jnci/95.7.516", "volume": "95", "author": "EJ Yeo", "year": "2003", "unstructured": "Yeo, E. J. et al. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J. Natl Cancer Inst. 95, 516\u2013525 (2003).", "journal-title": "J. Natl Cancer Inst."}, {"key": "BFnrc1367_CR92", "first-page": "374", "volume": "35", "author": "MJ Lemmon", "year": "1994", "unstructured": "Lemmon, M. J. et al. Anaerobic bacteria as a gene delivery system to tumors. Proc. Am. Assoc. Cancer Res. 35, 374 (1994).", "journal-title": "Proc. Am. Assoc. Cancer Res."}, {"key": "BFnrc1367_CR93", "first-page": "173", "volume": "3", "author": "ME Fox", "year": "1996", "unstructured": "Fox, M. E. et al. Anaerobic bacteria as a delivery system for cancer gene therapy: activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther. 3, 173\u2013178 (1996).", "journal-title": "Gene Ther."}, {"key": "BFnrc1367_CR94", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1038/sj.gt.3300468", "volume": "4", "author": "ML Lemmon", "year": "1997", "unstructured": "Lemmon, M. L. et al. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment. Gene Ther. 4, 791\u2013796 (1997).", "journal-title": "Gene Ther."}, {"key": "BFnrc1367_CR95", "first-page": "473", "volume": "15", "author": "RA Malmgren", "year": "1955", "unstructured": "Malmgren, R. A. & Flanigan, C. C. Localization of the vegetative form of Clostridium tetani in mouse tumors following intravenous spore administration. Cancer Res. 15, 473\u2013478 (1955).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR96", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1007/BF00531349", "volume": "63", "author": "JR M\u00f6se", "year": "1959", "unstructured": "M\u00f6se, J. R. & M\u00f6se, G. Onkolyseversuche mit apathogenen anaeroben Sporenbildern am Ehrlich Tumor des Maus. Z. Krebsforsch 63, 63\u201374 (1959).", "journal-title": "Z. Krebsforsch"}, {"key": "BFnrc1367_CR97", "first-page": "212", "volume": "24", "author": "JR M\u00f6se", "year": "1964", "unstructured": "M\u00f6se, J. R. & M\u00f6se, G. Oncolysis by clostridia. I. Activity of Clostridium butyricum (M-55) and other nonpathogenic clostridia against the Ehrlich carcinoma. Cancer Res. 24, 212\u2013216 (1964).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR98", "unstructured": "Thiele, E. H., Arison, R. N. & Boxer, G. E. Oncolysis by clostridia. III. Effects of clostridia and chemotherapeutic agents on rodent tumors. Cancer Res. 24 (1964)."}, {"key": "BFnrc1367_CR99", "first-page": "239", "volume": "24", "author": "K Engelbart", "year": "1964", "unstructured": "Engelbart, K. & Gericke, D. Oncolysis by clostridia V. Transplanted tumors of the hamster. Cancer Res. 24, 239\u2013243 (1964).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR100", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1016/0014-2964(67)90060-6", "volume": "3", "author": "RW Carey", "year": "1967", "unstructured": "Carey, R. W., Holland, J. F., Whang, H. Y., Neter, E. & Bryant, B. Clostridial oncolysis in man. Europ. J. Cancer 3, 37\u201346 (1967).", "journal-title": "Europ. J. Cancer"}, {"key": "BFnrc1367_CR101", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1007/BF01406639", "volume": "12", "author": "F Heppner", "year": "1978", "unstructured": "Heppner, F. & Mose, J. R. The liquefaction (oncolysis) of malignant gliomas by a non pathogenic clostridium. Acta Neuro. 12, 123\u2013125 (1978).", "journal-title": "Acta Neuro."}, {"key": "BFnrc1367_CR102", "first-page": "38", "volume": "226", "author": "F Heppner", "year": "1983", "unstructured": "Heppner, F., Mose, J., Ascher, P. W. & Walter, G. Oncolysis of malignant gliomas of the brain. 13th Int. Cong. Chemother. 226, 38\u201345 (1983).", "journal-title": "13th Int. Cong. Chemother."}, {"key": "BFnrc1367_CR103", "first-page": "4537", "volume": "57", "author": "JM Pawelek", "year": "1997", "unstructured": "Pawelek, J. M., Low, K. B. & Bermudes, D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57, 4537\u20134544 (1997).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR104", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1200/JCO.2002.20.1.142", "volume": "20", "author": "JF Toso", "year": "2002", "unstructured": "Toso, J. F. et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20, 142\u2013152 (2002).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1367_CR105", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1038/sj.gt.3301659", "volume": "9", "author": "SC Liu", "year": "2002", "unstructured": "Liu, S. C., Minton, N. P., Giaccia, A. J. & Brown, J. M. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis. Gene Ther. 9, 291\u2013296 (2002). First data demonstrating  in vivo  efficacy of CDEPT.", "journal-title": "Gene Ther."}, {"key": "BFnrc1367_CR106", "doi-asserted-by": "crossref", "first-page": "2362", "DOI": "10.1016/0959-8049(95)00436-X", "volume": "31A", "author": "JA Bridgewater", "year": "1995", "unstructured": "Bridgewater, J. A. et al. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954. Eur. J. Cancer 31A, 2362\u20132370 (1995).", "journal-title": "Eur. J. Cancer"}, {"key": "BFnrc1367_CR107", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1038/nrmicro777", "volume": "1", "author": "NP Minton", "year": "2003", "unstructured": "Minton, N. P. Clostridia in cancer therapy. Nat. Rev. Microbiol. 1, 237\u2013242 (2003).", "journal-title": "Nat. Rev. Microbiol."}, {"key": "BFnrc1367_CR108", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1007/s002800050646", "volume": "40", "author": "J Martin", "year": "1997", "unstructured": "Martin, J. et al. Antibody-directed enzyme prodrug therapy: pharmacokinetics and plasma levels of prodrug and drug in a phase I clinical trial. Cancer Chemother. Pharmacol. 40, 189\u2013201 (1997).", "journal-title": "Cancer Chemother. Pharmacol."}, {"key": "BFnrc1367_CR109", "first-page": "633", "volume": "59", "author": "WR Joseph", "year": "1999", "unstructured": "Joseph, W. R. et al. Stimulation of tumors to synthesize tumor necrosis factor-\u03b1 in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy. Cancer Res. 59, 633\u2013638 (1999).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR110", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1038/sj.bjc.6600479", "volume": "87", "author": "L Zhao", "year": "2002", "unstructured": "Zhao, L., Ching, L. M., Kestell, P. & Baguley, B. C. The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice. Br. J. Cancer 87, 465\u2013470 (2002).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1367_CR111", "doi-asserted-by": "crossref", "first-page": "1937", "DOI": "10.1038/sj.bjc.6600368", "volume": "86", "author": "LM Ching", "year": "2002", "unstructured": "Ching, L. M. et al. Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acid. Br. J. Cancer 86, 1937\u20131942 (2002).", "journal-title": "Br. J. Cancer"}, {"key": "BFnrc1367_CR112", "doi-asserted-by": "crossref", "first-page": "3826", "DOI": "10.1200/JCO.2002.09.144", "volume": "20", "author": "SM Galbraith", "year": "2002", "unstructured": "Galbraith, S. M. et al. Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging. J. Clin. Oncol. 20, 3826\u20133840 (2002).", "journal-title": "J. Clin. Oncol."}, {"key": "BFnrc1367_CR113", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1111/j.1574-695X.2001.tb01547.x", "volume": "30", "author": "J Theys", "year": "2001", "unstructured": "Theys, J. et al. Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas. FEMS Immunol. Med. Microbiol. 30, 37\u201341 (2001).", "journal-title": "FEMS Immunol. Med. Microbiol."}, {"key": "BFnrc1367_CR114", "doi-asserted-by": "crossref", "first-page": "15155", "DOI": "10.1073/pnas.251543698", "volume": "98", "author": "LH Dang", "year": "2001", "unstructured": "Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W. & Vogelstein, B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc. Natl Acad. Sci. USA 98, 15155\u201315160 (2001).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "BFnrc1367_CR115", "first-page": "5970", "volume": "63", "author": "KO Hicks", "year": "2003", "unstructured": "Hicks, K. O., Pruijn, F. B., Sturman, J. R., Denny, W. A. & Wilson, W. R. Multicellular resistance to tirapazamine is due to restricted extravascular transport in HT29 multicellular layer cultures: A pharmacokinetic/pharmacodynamic study. Cancer Res. 63, 5970\u20135977 (2003).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR116", "doi-asserted-by": "crossref", "first-page": "1084", "DOI": "10.1038/sj.bjc.6601612", "volume": "90", "author": "NA Helsby", "year": "2004", "unstructured": "Helsby, N. A., Ferry, D. M., Patterson, A. V., Pullen, S. M. & Wilson, W. R. 2\u2013amino metabolites are key mediatiors of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT. Br. J.Cancer 90, 1084\u20131092 (2004).", "journal-title": "Br. J.Cancer"}, {"key": "BFnrc1367_CR117", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/S0167-8140(03)00011-2", "volume": "67", "author": "J Bussink", "year": "2003", "unstructured": "Bussink, J., Kaanders, J. H. A. M. & van der Kogel, A. J. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exdogenous and endogenous hypoxic cell markers. Radiother. Oncol. 67, 3\u201315 (2003).", "journal-title": "Radiother. Oncol."}, {"key": "BFnrc1367_CR118", "doi-asserted-by": "crossref", "first-page": "1519", "DOI": "10.1016/0006-2952(69)90267-6", "volume": "18", "author": "LM Cobb", "year": "1969", "unstructured": "Cobb, L. M. et al. 2,4-Dinitro-5-ethyleneiminobenzamide (CB 1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256. Biochem. Pharmacol. 18, 1519\u20131527 (1969).", "journal-title": "Biochem. Pharmacol."}, {"key": "BFnrc1367_CR119", "doi-asserted-by": "crossref", "first-page": "4661", "DOI": "10.1016/0006-2952(88)90335-8", "volume": "37", "author": "RJ Knox", "year": "1988", "unstructured": "Knox, R. J., Friedlos, F., Jarman, M. & Roberts, J. J. A new cytotoxic, DNA interstrand crosslinking agent, 5-(Aziridin-1-YL)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(Aziridin-1-YL)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells. Biochem. Pharm. 37, 4661\u20134669 (1988).", "journal-title": "Biochem. Pharm."}, {"key": "BFnrc1367_CR120", "doi-asserted-by": "crossref", "first-page": "4671", "DOI": "10.1016/0006-2952(88)90336-X", "volume": "37", "author": "RJ Knox", "year": "1988", "unstructured": "Knox, R. J. et al. The nitroreductase enzyme in Walker cells that activates 5-(Aziridin-1-YL)-2,4-dinitrobenzamide (CB 1954) to 5-(Aziridin-1-YL)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1. 6. 99. 2). Biochem. Pharmacol. 37, 4671\u20134677 (1988).", "journal-title": "Biochem. Pharmacol."}, {"key": "BFnrc1367_CR121", "doi-asserted-by": "crossref", "first-page": "2289", "DOI": "10.1016/0006-2952(92)90671-5", "volume": "44", "author": "GM Anlezark", "year": "1992", "unstructured": "Anlezark, G. M. et al. The bioactivation of 5-(Aziridin-1-YL)-2,4-dinitrobenzamide (CB 1954)-I Purification and properties of a nitroreductase enzyme from Escherichia Coli: A potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT). Biochem. Pharmacol. 44, 2289\u20132295 (1992).", "journal-title": "Biochem. Pharmacol."}, {"key": "BFnrc1367_CR122", "first-page": "2662", "volume": "7", "author": "G Chung-Faye", "year": "2001", "unstructured": "Chung-Faye, G. et al. Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954. Clin. Cancer Res. 7, 2662\u20132668 (2001).", "journal-title": "Clin. Cancer Res."}, {"key": "BFnrc1367_CR123", "doi-asserted-by": "crossref", "first-page": "502", "DOI": "10.2307/3575639", "volume": "88", "author": "IJ Stratford", "year": "1981", "unstructured": "Stratford, I. J., Williamson, C., Hoe, S. & Adams, G. E. Radiosensitizing and cytotoxicity studies with CB 1954 (2,4-dinitro-5-aziridinylbenzamide). Radiat. Res. 88, 502\u2013509 (1981).", "journal-title": "Radiat. Res."}, {"key": "BFnrc1367_CR124", "doi-asserted-by": "crossref", "first-page": "3214", "DOI": "10.1021/jm00095a018", "volume": "35", "author": "BD Palmer", "year": "1992", "unstructured": "Palmer, B. D., Wilson, W. R., Cliffe, S. & Denny, W. A. Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells. J. Med. Chem. 35, 3214\u20133222 (1992).", "journal-title": "J. Med. Chem."}, {"key": "BFnrc1367_CR125", "first-page": "1408", "volume": "58", "author": "JM Brown", "year": "1998", "unstructured": "Brown, J. M. & Giaccia, A. J. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408\u20131416 (1998).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR126", "first-page": "145", "volume": "61", "author": "BG Wouters", "year": "2001", "unstructured": "Wouters, B. G. et al. Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine. Cancer Res. 61, 145\u2013152 (2001).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR127", "first-page": "2911", "volume": "61", "author": "DM Aebersold", "year": "2001", "unstructured": "Aebersold, D. M. et al. Expression of hypoxia-inducible factor-1\u03b1: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61, 2911\u20132916 (2001). Shows that HIF-1 can be used as an endogenous marker of tumour hypoxia to predict response to radiotherapy.", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR128", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1016/0360-3016(94)90432-4", "volume": "29", "author": "R Rampling", "year": "1994", "unstructured": "Rampling, R., Cruickshank, G., Lewis, A. D., Fitzsimmons, S. A. & Workman, P. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 29, 427\u2013431 (1994).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR129", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1016/S0167-8140(99)00121-8", "volume": "53", "author": "DR Collingridge", "year": "1999", "unstructured": "Collingridge, D. R., Piepmeier, J. M., Rockwell, S. & Knisely, J. P. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother. Oncol. 53, 127\u2013131 (1999).", "journal-title": "Radiother. Oncol."}, {"key": "BFnrc1367_CR130", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.3109/02841869409098433", "volume": "33", "author": "M Nordsmark", "year": "1994", "unstructured": "Nordsmark, M., Bentzen, S. M. & Overgaard, J. Measurement of human tumour oxygenation status by a polarographic needle electrode. Acta Oncol. 33, 383\u2013389 (1994).", "journal-title": "Acta Oncol."}, {"key": "BFnrc1367_CR131", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/S0360-3016(98)00182-5", "volume": "42", "author": "A Becker", "year": "1998", "unstructured": "Becker, A. et al. Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int. J. Radiat. Oncol. Biol. Phys. 42, 35\u201341 (1998).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR132", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1016/S0360-3016(02)04503-0", "volume": "56", "author": "QT Le", "year": "2003", "unstructured": "Le, Q. T. et al. Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 56, 375\u2013383 (2003).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR133", "doi-asserted-by": "crossref", "first-page": "334", "DOI": "10.1046/j.1563-258X.2002.02032.x", "volume": "152", "author": "P Vaupel", "year": "2002", "unstructured": "Vaupel, P., Briest, S. & Hockel, M. Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications. Wien. Med. Wochenschr. 152, 334\u2013342 (2002).", "journal-title": "Wien. Med. Wochenschr."}, {"key": "BFnrc1367_CR134", "doi-asserted-by": "crossref", "first-page": "919", "DOI": "10.1016/S0360-3016(00)00803-8", "volume": "48", "author": "AC Koong", "year": "2000", "unstructured": "Koong, A. C. et al. Pancreatic tumors show high levels of hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 48, 919\u2013922 (2000).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}, {"key": "BFnrc1367_CR135", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1016/S0167-8140(97)01920-8", "volume": "44", "author": "H Lyng", "year": "1997", "unstructured": "Lyng, H., Sundfor, K. & Rofstad, E. K. Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia. Radiother. Oncol. 44, 163\u2013169 (1997).", "journal-title": "Radiother. Oncol."}, {"key": "BFnrc1367_CR136", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1016/S0167-8140(98)00044-9", "volume": "48", "author": "AW Fyles", "year": "1998", "unstructured": "Fyles, A. W. et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother. Oncol. 48, 149\u2013156 (1998).", "journal-title": "Radiother. Oncol."}, {"key": "BFnrc1367_CR137", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/S0167-8140(03)00010-0", "volume": "67", "author": "M Nordsmark", "year": "2003", "unstructured": "Nordsmark, M. et al. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother. Oncol. 67, 35\u201344 (2003).", "journal-title": "Radiother. Oncol."}, {"key": "BFnrc1367_CR138", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.1097/00000421-200110000-00009", "volume": "24", "author": "B Movsas", "year": "2001", "unstructured": "Movsas, B. et al. Hypoxia in human prostate carcinoma: an Eppendorf PO2 study. Am. J. Clin. Oncol. 24, 458\u2013461 (2001).", "journal-title": "Am. J. Clin. Oncol."}, {"key": "BFnrc1367_CR139", "first-page": "5347", "volume": "56", "author": "DM Brizel", "year": "1996", "unstructured": "Brizel, D. M. et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 56, 5347\u20135350 (1996).", "journal-title": "Cancer Res."}, {"key": "BFnrc1367_CR140", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.1016/0360-3016(96)00132-0", "volume": "35", "author": "M Nordsmark", "year": "1996", "unstructured": "Nordsmark, M. et al. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 35, 701\u2013708 (1996).", "journal-title": "Int. J. Radiat. Oncol. Biol. Phys."}], "container-title": ["Nature Reviews Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/nrc1367.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrc1367", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/nrc1367.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T17:38:49Z", "timestamp": 1552844329000}, "score": 41.88879, "issued": {"date-parts": [[2004, 6]]}, "references-count": 140, "journal-issue": {"published-print": {"date-parts": [[2004, 6]]}, "issue": "6"}, "alternative-id": ["BFnrc1367"], "URL": "http://dx.doi.org/10.1038/nrc1367", "relation": {"cites": []}, "ISSN": ["1474-175X", "1474-1768"], "issn-type": [{"value": "1474-175X", "type": "print"}, {"value": "1474-1768", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:13Z", "timestamp": 1574488993572}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1993, 6, 1]], "date-time": "1993-06-01T00:00:00Z", "timestamp": 738892800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1993, 6]]}, "DOI": "10.1038/bjc.1993.220", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:06:18Z", "timestamp": 1295003178000}, "page": "1163-1170", "source": "Crossref", "is-referenced-by-count": 220, "title": ["SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours"], "prefix": "10.1038", "volume": "67", "author": [{"given": "JM", "family": "Brown", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1993220.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1993220", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1993220.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T20:09:55Z", "timestamp": 1552766995000}, "score": 39.19918, "issued": {"date-parts": [[1993, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 6]]}, "issue": "6"}, "alternative-id": ["BFbjc1993220"], "URL": "http://dx.doi.org/10.1038/bjc.1993.220", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T04:34:48Z", "timestamp": 1575434088037}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "8", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "short-container-title": ["Cancer Res"], "published-print": {"date-parts": [[2019, 4, 15]]}, "DOI": "10.1158/0008-5472.can-18-3631", "type": "journal-article", "created": {"date-parts": [[2019, 4, 9]], "date-time": "2019-04-09T18:54:54Z", "timestamp": 1554836094000}, "page": "1730-1739", "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Exploiting DNA Replication Stress for Cancer Treatment"], "prefix": "10.1158", "volume": "79", "author": [{"ORCID": "http://orcid.org/0000-0002-9107-1888", "authenticated-orcid": false, "given": "Tajinder", "family": "Ubhi", "sequence": "first", "affiliation": []}, {"given": "Grant W.", "family": "Brown", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2019, 4, 9]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-18-3631", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 6]], "date-time": "2019-06-06T19:16:02Z", "timestamp": 1559848562000}, "score": 26.572952, "issued": {"date-parts": [[2019, 4, 9]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2019, 4, 15]]}, "published-print": {"date-parts": [[2019, 4, 15]]}, "issue": "8"}, "alternative-id": ["10.1158/0008-5472.CAN-18-3631"], "URL": "http://dx.doi.org/10.1158/0008-5472.can-18-3631", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:02:48Z", "timestamp": 1574488968580}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1989, 3, 1]], "date-time": "1989-03-01T00:00:00Z", "timestamp": 604713600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1989, 3]]}, "DOI": "10.1038/bjc.1989.69", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T10:38:09Z", "timestamp": 1295001489000}, "page": "349-352", "source": "Crossref", "is-referenced-by-count": 15, "title": ["The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice"], "prefix": "10.1038", "volume": "59", "author": [{"given": "MP", "family": "MacManus", "sequence": "first", "affiliation": []}, {"given": "AP", "family": "Maxwell", "sequence": "additional", "affiliation": []}, {"given": "WP", "family": "Abram", "sequence": "additional", "affiliation": []}, {"given": "JM", "family": "Bridges", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc198969.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc198969", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc198969.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T03:47:38Z", "timestamp": 1552708058000}, "score": 26.512033, "issued": {"date-parts": [[1989, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1989, 3]]}, "issue": "3"}, "alternative-id": ["BFbjc198969"], "URL": "http://dx.doi.org/10.1038/bjc.1989.69", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:14Z", "timestamp": 1574488994179}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1993, 2, 1]], "date-time": "1993-02-01T00:00:00Z", "timestamp": 728524800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1993, 2]]}, "DOI": "10.1038/bjc.1993.59", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:04:54Z", "timestamp": 1295003094000}, "page": "321-325", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studies"], "prefix": "10.1038", "volume": "67", "author": [{"given": "J", "family": "Wang", "sequence": "first", "affiliation": []}, {"given": "KA", "family": "Biedermann", "sequence": "additional", "affiliation": []}, {"given": "CR", "family": "Wolf", "sequence": "additional", "affiliation": []}, {"given": "JM", "family": "Brown", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc199359.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc199359", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc199359.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T20:10:40Z", "timestamp": 1552767040000}, "score": 24.588236, "issued": {"date-parts": [[1993, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 2]]}, "issue": "2"}, "alternative-id": ["BFbjc199359"], "URL": "http://dx.doi.org/10.1038/bjc.1993.59", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T23:17:01Z", "timestamp": 1574119021024}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 9, 1]], "date-time": "2003-09-01T00:00:00Z", "timestamp": 1062374400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2003, 9]]}, "DOI": "10.1016/s1359-6349(03)90783-x", "type": "journal-article", "created": {"date-parts": [[2004, 4, 18]], "date-time": "2004-04-18T02:00:02Z", "timestamp": 1082253602000}, "page": "S227", "source": "Crossref", "is-referenced-by-count": 0, "title": ["757 Hypoxic tumour environment and its implication for cancer treatment"], "prefix": "10.1016", "volume": "1", "author": [{"given": "M.", "family": "Brown", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S135963490390783X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S135963490390783X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 13]], "date-time": "2019-02-13T03:59:02Z", "timestamp": 1550030342000}, "score": 24.54683, "issued": {"date-parts": [[2003, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 9]]}, "issue": "5"}, "alternative-id": ["S135963490390783X"], "URL": "http://dx.doi.org/10.1016/s1359-6349(03)90783-x", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:43Z", "timestamp": 1574489023595}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1996, 4, 1]], "date-time": "1996-04-01T00:00:00Z", "timestamp": 828316800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1996, 4]]}, "DOI": "10.1038/bjc.1996.187", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:37:15Z", "timestamp": 1295005035000}, "page": "952-960", "source": "Crossref", "is-referenced-by-count": 32, "title": ["Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro"], "prefix": "10.1038", "volume": "73", "author": [{"given": "BG", "family": "Siim", "sequence": "first", "affiliation": []}, {"given": "PL", "family": "van Zijl", "sequence": "additional", "affiliation": []}, {"given": "JM", "family": "Brown", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1996187.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1996187", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1996187.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T21:15:13Z", "timestamp": 1552770913000}, "score": 24.452215, "issued": {"date-parts": [[1996, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 4]]}, "issue": "8"}, "alternative-id": ["BFbjc1996187"], "URL": "http://dx.doi.org/10.1038/bjc.1996.187", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:08Z", "timestamp": 1574488988795}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1992, 9, 1]], "date-time": "1992-09-01T00:00:00Z", "timestamp": 715305600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1992, 9]]}, "DOI": "10.1038/bjc.1992.290", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T10:58:48Z", "timestamp": 1295002728000}, "page": "424-426", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges"], "prefix": "10.1038", "volume": "66", "author": [{"given": "JM", "family": "Birch", "sequence": "first", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1992290.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1992290", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1992290.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T06:18:05Z", "timestamp": 1552889885000}, "score": 23.749485, "issued": {"date-parts": [[1992, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 9]]}, "issue": "3"}, "alternative-id": ["BFbjc1992290"], "URL": "http://dx.doi.org/10.1038/bjc.1992.290", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:13Z", "timestamp": 1574488993138}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1993, 4, 1]], "date-time": "1993-04-01T00:00:00Z", "timestamp": 733622400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1993, 4]]}, "DOI": "10.1038/bjc.1993.148", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:07:02Z", "timestamp": 1295003222000}, "page": "813-818", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Wilms' tumour and parental age: a report from the National Wilms' Tumour Study"], "prefix": "10.1038", "volume": "67", "author": [{"given": "JM", "family": "Olson", "sequence": "first", "affiliation": []}, {"given": "NE", "family": "Breslow", "sequence": "additional", "affiliation": []}, {"given": "JB", "family": "Beckwith", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1993148.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1993148", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1993148.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T20:09:08Z", "timestamp": 1552766948000}, "score": 23.72668, "issued": {"date-parts": [[1993, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 4]]}, "issue": "4"}, "alternative-id": ["BFbjc1993148"], "URL": "http://dx.doi.org/10.1038/bjc.1993.148", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:14Z", "timestamp": 1574488994424}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1992, 12, 1]], "date-time": "1992-12-01T00:00:00Z", "timestamp": 723168000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1992, 12]]}, "DOI": "10.1038/bjc.1992.409", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:03:18Z", "timestamp": 1295002998000}, "page": "1053-1058", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Enhancement of the cytotoxicity of SR 4233 to normal and malignant tissues by hypoxic breathing"], "prefix": "10.1038", "volume": "66", "author": [{"given": "AI", "family": "Minchinton", "sequence": "first", "affiliation": []}, {"given": "JM", "family": "Brown", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1992409.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1992409", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1992409.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T06:19:38Z", "timestamp": 1552889978000}, "score": 22.886581, "issued": {"date-parts": [[1992, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 12]]}, "issue": "6"}, "alternative-id": ["BFbjc1992409"], "URL": "http://dx.doi.org/10.1038/bjc.1992.409", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T23:43:15Z", "timestamp": 1576885395473}, "reference-count": 109, "publisher": "Elsevier", "isbn-type": [{"value": "9780123739704", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2007]]}, "DOI": "10.1016/s0076-6879(07)35015-5", "type": "book-chapter", "created": {"date-parts": [[2007, 12, 1]], "date-time": "2007-12-01T08:55:16Z", "timestamp": 1196499316000}, "page": "295-321", "source": "Crossref", "is-referenced-by-count": 46, "title": ["Tumor Hypoxia in Cancer Therapy"], "prefix": "10.1016", "author": [{"given": "J. Martin", "family": "Brown", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Methods in Enzymology", "Oxygen Biology and Hypoxia"], "deposited": {"date-parts": [[2019, 5, 5]], "date-time": "2019-05-05T12:00:07Z", "timestamp": 1557057607000}, "score": 22.28378, "issued": {"date-parts": [[2007]]}, "ISBN": ["9780123739704"], "references-count": 109, "URL": "http://dx.doi.org/10.1016/s0076-6879(07)35015-5", "ISSN": ["0076-6879"], "issn-type": [{"value": "0076-6879", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T13:37:30Z", "timestamp": 1574170650699}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1988, 8, 1]], "date-time": "1988-08-01T00:00:00Z", "timestamp": 586396800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Computer Communications"], "published-print": {"date-parts": [[1988, 8]]}, "DOI": "10.1016/0140-3664(88)90086-2", "type": "journal-article", "created": {"date-parts": [[2003, 8, 7]], "date-time": "2003-08-07T22:34:07Z", "timestamp": 1060295647000}, "page": "221", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Exploiting integrated voice and data networks"], "prefix": "10.1016", "volume": "11", "author": [{"given": "JM", "family": "Griffiths", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Computer Communications"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0140366488900862?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0140366488900862?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 15]], "date-time": "2019-03-15T08:23:32Z", "timestamp": 1552638212000}, "score": 21.537281, "issued": {"date-parts": [[1988, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1988, 8]]}, "issue": "4"}, "alternative-id": ["0140366488900862"], "URL": "http://dx.doi.org/10.1016/0140-3664(88)90086-2", "ISSN": ["0140-3664"], "issn-type": [{"value": "0140-3664", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T16:11:24Z", "timestamp": 1574439084678}, "reference-count": 55, "publisher": "Informa UK Limited", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Journal of Radiation Biology"], "published-print": {"date-parts": [[2010, 11]]}, "DOI": "10.3109/09553002.2010.492492", "type": "journal-article", "created": {"date-parts": [[2010, 6, 23]], "date-time": "2010-06-23T08:16:44Z", "timestamp": 1277281004000}, "page": "907-917", "source": "Crossref", "is-referenced-by-count": 11, "title": ["The remarkable yin and yang of tumour hypoxia"], "prefix": "10.1080", "volume": "86", "author": [{"given": "Martin", "family": "Brown", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2010, 6, 23]]}, "reference": [{"key": "CIT0001", "DOI": "10.1016/j.ccr.2007.11.032", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "author": "Alper T", "volume": "178", "first-page": "978", "year": "1956", "journal-title": "coli B. Nature", "DOI": "10.1038/178978a0", "doi-asserted-by": "crossref"}, {"key": "CIT0003", "author": "Anderson RF", "volume": "125", "first-page": "748", "year": "2003", "journal-title": "Journal of American Chemical Society", "DOI": "10.1021/ja0209363", "doi-asserted-by": "crossref"}, {"key": "CIT0004", "author": "Asahara T", "volume": "275", "first-page": "964", "year": "1997", "journal-title": "Science", "DOI": "10.1126/science.275.5302.964", "doi-asserted-by": "crossref"}, {"key": "CIT0005", "author": "Brizel DM", "volume": "53", "first-page": "113", "year": "1999", "journal-title": "Radiotherapy and Oncology", "DOI": "10.1016/S0167-8140(99)00102-4", "doi-asserted-by": "crossref"}, {"key": "CIT0006", "author": "Brown JM", "volume": "64", "first-page": "633", "year": "1975", "journal-title": "Radiation Research", "DOI": "10.2307/3574253", "doi-asserted-by": "crossref"}, {"key": "CIT0007", "author": "Brown JM", "volume": "72", "first-page": "469", "year": "1977", "journal-title": "Radiation Research", "DOI": "10.2307/3574611", "doi-asserted-by": "crossref"}, {"key": "CIT0008", "author": "Brown JM", "volume": "52", "first-page": "650", "year": "1979", "journal-title": "British Journal of Radiology", "DOI": "10.1259/0007-1285-52-620-650", "doi-asserted-by": "crossref"}, {"key": "CIT0009", "author": "Brown JM", "volume": "6", "first-page": "157", "year": "2000", "journal-title": "Molecular Medicine Today", "DOI": "10.1016/S1357-4310(00)01677-4", "doi-asserted-by": "crossref"}, {"key": "CIT0010", "author": "Brown JM", "volume": "435", "first-page": "298", "year": "2007", "journal-title": "Methods in Enzymology"}, {"key": "CIT0011", "author": "Brown JM", "volume": "7", "first-page": "695", "year": "1981", "journal-title": "International Journal of Radiation Oncology, Biology, and Physics", "DOI": "10.1016/0360-3016(81)90460-0", "doi-asserted-by": "crossref"}, {"key": "CIT0012", "author": "Budach W", "volume": "85", "first-page": "988", "year": "1993", "journal-title": "Journal of National Cancer Institute", "DOI": "10.1093/jnci/85.12.988", "doi-asserted-by": "crossref"}, {"key": "CIT0013", "author": "Bussink J", "volume": "67", "first-page": "3", "year": "2003", "journal-title": "Radiotherapy and Oncology", "DOI": "10.1016/S0167-8140(03)00011-2", "doi-asserted-by": "crossref"}, {"key": "CIT0014", "author": "Chaplin DJ", "volume": "47", "first-page": "597", "year": "1987", "journal-title": "Cancer Research"}, {"key": "CIT0015", "author": "Churchill-Davidson I", "volume": "88", "first-page": "125", "year": "1958", "journal-title": "Medical World Journal"}, {"key": "CIT0016", "author": "Coffelt SB", "volume": "1796", "first-page": "11", "year": "2009", "journal-title": "Biochimestry Biophysics Acta"}, {"key": "CIT0017", "author": "Denekamp J", "volume": "55", "first-page": "657", "year": "1982", "journal-title": "British Journal of Radiology", "DOI": "10.1259/0007-1285-55-657-657", "doi-asserted-by": "crossref"}, {"key": "CIT0018", "author": "Dische S", "volume": "37", "first-page": "311", "year": "1978", "journal-title": "British Journal of Cancer"}, {"key": "CIT0019", "author": "Evans JW", "volume": "68", "first-page": "257", "year": "2008", "journal-title": "Cancer Research", "DOI": "10.1158/0008-5472.CAN-06-4497", "doi-asserted-by": "crossref"}, {"key": "CIT0020", "DOI": "10.1126/science.1082504", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "author": "Gerber HP", "volume": "273", "first-page": "30336", "year": "1998", "journal-title": "Journal of Biological Chemistry", "DOI": "10.1074/jbc.273.46.30336", "doi-asserted-by": "crossref"}, {"key": "CIT0022", "author": "Gray LH", "volume": "26", "first-page": "638", "year": "1953", "journal-title": "British Journal of Radiology", "DOI": "10.1259/0007-1285-26-312-638", "doi-asserted-by": "crossref"}, {"key": "CIT0023", "author": "Hall EJ", "volume": "117", "first-page": "453", "year": "1975", "journal-title": "Radiology", "DOI": "10.1148/117.2.453", "doi-asserted-by": "crossref"}, {"key": "CIT0024", "author": "Hay MP", "volume": "50", "first-page": "6392", "year": "2007", "journal-title": "Journal of Medicinal Chemistry", "DOI": "10.1021/jm070670g", "doi-asserted-by": "crossref"}, {"key": "CIT0025", "author": "Hill RP", "volume": "12", "first-page": "1049", "year": "1986", "journal-title": "International Journal of Radiation Oncology, Biology, and Physics", "DOI": "10.1016/0360-3016(86)90223-3", "doi-asserted-by": "crossref"}, {"key": "CIT0026", "author": "Hill RP", "year": "1992", "edition": "2", "volume-title": "The basic science of oncology"}, {"key": "CIT0027", "author": "Jameson MB", "volume": "65", "first-page": "791", "year": "2010", "journal-title": "Cancer Chemotherapy Pharmacology", "DOI": "10.1007/s00280-009-1188-1", "doi-asserted-by": "crossref"}, {"key": "CIT0028", "author": "Janssen HL", "volume": "27", "first-page": "622", "year": "2005", "journal-title": "Head and Neck", "DOI": "10.1002/hed.20223", "doi-asserted-by": "crossref"}, {"key": "CIT0029", "author": "Kallman RF", "volume": "105", "first-page": "135", "year": "1972", "journal-title": "Radiology", "DOI": "10.1148/105.1.135", "doi-asserted-by": "crossref"}, {"key": "CIT0030", "author": "Kaplan HS", "volume": "10", "first-page": "275", "year": "1974", "journal-title": "European Journal of Cancer", "DOI": "10.1016/S0014-2964(74)80016-2", "doi-asserted-by": "crossref"}, {"key": "CIT0031", "author": "Kioi M", "volume": "120", "first-page": "694", "year": "2010", "journal-title": "Journal of Clinical Investigation", "DOI": "10.1172/JCI40283", "doi-asserted-by": "crossref"}, {"key": "CIT0032", "author": "Koch CJ", "volume": "53", "first-page": "3992", "year": "1993", "journal-title": "Cancer Research"}, {"key": "CIT0033", "author": "Lanzen J", "volume": "66", "first-page": "2219", "year": "2006", "journal-title": "Cancer Research", "DOI": "10.1158/0008-5472.CAN-03-2958", "doi-asserted-by": "crossref"}, {"key": "CIT0034", "author": "Lee D-J", "volume": "32", "first-page": "567", "year": "1995", "journal-title": "International Journal of Radiation Oncology, Biology, and Physics", "DOI": "10.1016/0360-3016(95)00150-W", "doi-asserted-by": "crossref"}, {"key": "CIT0035", "author": "Moeller BJ", "volume": "5", "first-page": "429", "year": "2004", "journal-title": "Cancer Cell", "DOI": "10.1016/S1535-6108(04)00115-1", "doi-asserted-by": "crossref"}, {"key": "CIT0036", "author": "Mohindra JK", "volume": "36", "first-page": "930", "year": "1976", "journal-title": "Cancer Research"}, {"key": "CIT0037", "author": "Movsas B", "volume": "60", "first-page": "634", "year": "2002", "journal-title": "Urology", "DOI": "10.1016/S0090-4295(02)01858-7", "doi-asserted-by": "crossref"}, {"key": "CIT0038", "author": "Nordsmark M", "volume": "33", "first-page": "383", "year": "1994", "journal-title": "Acta Oncology", "DOI": "10.3109/02841869409098433", "doi-asserted-by": "crossref"}, {"key": "CIT0039", "author": "Nordsmark M", "volume": "41", "first-page": "31", "year": "1996", "journal-title": "Radiotherapy and Oncology", "DOI": "10.1016/S0167-8140(96)01811-7", "doi-asserted-by": "crossref"}, {"key": "CIT0040", "author": "Overgaard J", "volume": "25", "first-page": "4066", "year": "2007", "journal-title": "Journal of Clinical Oncology", "DOI": "10.1200/JCO.2007.12.7878", "doi-asserted-by": "crossref"}, {"key": "CIT0041", "author": "Patterson AV", "volume": "13", "first-page": "3922", "year": "2007", "journal-title": "Clinical Cancer Research", "DOI": "10.1158/1078-0432.CCR-07-0478", "doi-asserted-by": "crossref"}, {"key": "CIT0042", "author": "Peters LJ", "volume": "45", "first-page": "148", "year": "1999", "journal-title": "International Journal of Radiation Oncology, Biology, and Physics", "DOI": "10.1016/S0360-3016(99)90026-3", "doi-asserted-by": "crossref"}, {"key": "CIT0043", "author": "Peters LJ", "year": "2007", "volume-title": "Abstract PS1042"}, {"key": "CIT0044", "author": "Rischin D", "volume": "23", "first-page": "79", "year": "2005", "journal-title": "Journal of Clinical Oncology", "DOI": "10.1200/JCO.2005.01.072", "doi-asserted-by": "crossref"}, {"key": "CIT0045", "author": "Rischin D", "year": "2008", "journal-title": "Journal of Clinical Oncology 26: Abstract 2008 ASCO Annual Meeting Proceedings"}, {"key": "CIT0046", "author": "Sheldon PW", "volume": "30", "first-page": "560", "year": "1974", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1974.235", "doi-asserted-by": "crossref"}, {"key": "CIT0047", "author": "Stone HB", "volume": "48", "first-page": "411", "year": "1975", "journal-title": "British Journal of Radiology", "DOI": "10.1259/0007-1285-48-569-411", "doi-asserted-by": "crossref"}, {"key": "CIT0048", "author": "Suit HD", "volume": "116", "first-page": "482", "year": "1988", "journal-title": "Radiation Research", "DOI": "10.2307/3577391", "doi-asserted-by": "crossref"}, {"key": "CIT0049", "author": "Sutherland RM", "volume": "6", "first-page": "117", "year": "1980", "journal-title": "International Journal of Radiation Oncology, Biology, and Physics", "DOI": "10.1016/0360-3016(80)90215-1", "doi-asserted-by": "crossref"}, {"key": "CIT0050", "author": "Thomlinson RH", "volume": "9", "first-page": "539", "year": "1955", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1955.55", "doi-asserted-by": "crossref"}, {"key": "CIT0051", "author": "Trotter MJ", "volume": "59", "first-page": "706", "year": "1989", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1989.148", "doi-asserted-by": "crossref"}, {"key": "CIT0052", "author": "Wouters BG", "volume": "147", "first-page": "541", "year": "1997", "journal-title": "Radiation Research", "DOI": "10.2307/3579620", "doi-asserted-by": "crossref"}, {"key": "CIT0053", "author": "Yamaura H", "volume": "35", "first-page": "201", "year": "1979", "journal-title": "International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine", "DOI": "10.1080/09553007914550241", "doi-asserted-by": "crossref"}, {"key": "CIT0054", "author": "Yang L", "volume": "6", "first-page": "409", "year": "2004", "journal-title": "Cancer Cell", "DOI": "10.1016/j.ccr.2004.08.031", "doi-asserted-by": "crossref"}, {"key": "CIT0055", "author": "Zagorevskii D", "volume": "14", "first-page": "881", "year": "2003", "journal-title": "Insights into the mechanism of metabolic transformations and the characterization of reaction intermediates. Journal of American Society Mass Spectrometry"}], "container-title": ["International Journal of Radiation Biology"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.3109/09553002.2010.492492", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T09:50:12Z", "timestamp": 1497865812000}, "score": 21.411842, "issued": {"date-parts": [[2010, 6, 23]]}, "references-count": 55, "journal-issue": {"published-online": {"date-parts": [[2010, 6, 23]]}, "published-print": {"date-parts": [[2010, 11]]}, "issue": "11"}, "alternative-id": ["10.3109/09553002.2010.492492"], "URL": "http://dx.doi.org/10.3109/09553002.2010.492492", "relation": {"cites": []}, "ISSN": ["0955-3002", "1362-3095"], "issn-type": [{"value": "0955-3002", "type": "print"}, {"value": "1362-3095", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:39:14Z", "timestamp": 1574512754335}, "reference-count": 36, "publisher": "Springer Science and Business Media LLC", "issue": "12", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2011, 5, 17]], "date-time": "2011-05-17T00:00:00Z", "timestamp": 1305590400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[2011, 6]]}, "DOI": "10.1038/bjc.2011.169", "type": "journal-article", "created": {"date-parts": [[2011, 5, 17]], "date-time": "2011-05-17T19:56:12Z", "timestamp": 1305662172000}, "page": "1805-1809", "source": "Crossref", "is-referenced-by-count": 43, "title": ["Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas"], "prefix": "10.1038", "volume": "104", "author": [{"given": "D", "family": "Tseng", "sequence": "first", "affiliation": []}, {"given": "D A", "family": "Vasquez-Medrano", "sequence": "additional", "affiliation": []}, {"given": "J M", "family": "Brown", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 5, 17]]}, "reference": [{"issue": "18", "key": "BFbjc2011169_CR1", "doi-asserted-by": "publisher", "first-page": "9054", "DOI": "10.1158/0008-5472.CAN-05-3759", "volume": "66", "author": "M Aghi", "year": "2006", "unstructured": "Aghi M, Cohen KS, Klein RJ, Scadden DT, Chiocca EA (2006) Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res 66 (18): 9054\u20139064", "journal-title": "Cancer Res"}, {"issue": "3", "key": "BFbjc2011169_CR2", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1016/j.ccr.2007.11.032", "volume": "13", "author": "GO Ahn", "year": "2008", "unstructured": "Ahn GO, Brown JM (2008) Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13 (3): 193\u2013205", "journal-title": "Cancer Cell"}, {"issue": "18", "key": "BFbjc2011169_CR3", "doi-asserted-by": "publisher", "first-page": "8363", "DOI": "10.1073/pnas.0911378107", "volume": "107", "author": "GO Ahn", "year": "2010", "unstructured": "Ahn GO, Tseng D, Liao CH, Dorie MJ, Czechowicz A, Brown JM (2010) Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci USA 107 (18): 8363\u20138368", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "4", "key": "BFbjc2011169_CR4", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1161/01.RES.0000259562.63718.35", "volume": "100", "author": "A Aicher", "year": "2007", "unstructured": "Aicher A, Rentsch M, Sasaki K, Ellwart JW, Fandrich F, Siebert R, Cooke JP, Dimmeler S, Heeschen C (2007) Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 100 (4): 581\u2013589", "journal-title": "Circ Res"}, {"issue": "1", "key": "BFbjc2011169_CR5", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1084/jem.185.1.111", "volume": "185", "author": "A Aiuti", "year": "1997", "unstructured": "Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC (1997) The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 185 (1): 111\u2013120", "journal-title": "J Exp Med"}, {"issue": "12", "key": "BFbjc2011169_CR6", "doi-asserted-by": "publisher", "first-page": "988", "DOI": "10.1093/jnci/85.12.988", "volume": "85", "author": "W Budach", "year": "1993", "unstructured": "Budach W, Taghian A, Freeman J, Gioioso D, Suit HD (1993) Impact of stromal sensitivity on radiation response of tumors. J Natl Cancer Inst 85 (12): 988\u2013993", "journal-title": "J Natl Cancer Inst"}, {"issue": "9", "key": "BFbjc2011169_CR7", "doi-asserted-by": "publisher", "first-page": "2201", "DOI": "10.1084/jem.20052144", "volume": "203", "author": "JM Burns", "year": "2006", "unstructured": "Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203(9): 2201\u20132213", "journal-title": "J Exp Med"}, {"issue": "8", "key": "BFbjc2011169_CR8", "doi-asserted-by": "publisher", "first-page": "858", "DOI": "10.1038/nm1075", "volume": "10", "author": "DJ Ceradini", "year": "2004", "unstructured": "Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10 (8): 858\u2013864", "journal-title": "Nat Med"}, {"issue": "3", "key": "BFbjc2011169_CR9", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1016/j.ccr.2005.08.002", "volume": "8", "author": "M De Palma", "year": "2005", "unstructured": "De Palma M, Venneri MA, Galli R, Sergi LS, Politi LS, Sampaolesi M, Naldini L (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8 (3): 211\u2013226", "journal-title": "Cancer Cell"}, {"issue": "36", "key": "BFbjc2011169_CR10", "doi-asserted-by": "publisher", "first-page": "23169", "DOI": "10.1074/jbc.273.36.23169", "volume": "273", "author": "RK Ganju", "year": "1998", "unstructured": "Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W, Groopman JE (1998) The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273 (36): 23169\u201323175", "journal-title": "J Biol Chem"}, {"issue": "5622", "key": "BFbjc2011169_CR11", "doi-asserted-by": "publisher", "first-page": "1155", "DOI": "10.1126/science.1082504", "volume": "300", "author": "M Garcia-Barros", "year": "2003", "unstructured": "Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300 (5622): 1155\u20131159", "journal-title": "Science"}, {"issue": "3", "key": "BFbjc2011169_CR12", "doi-asserted-by": "publisher", "first-page": "194", "DOI": "10.1038/nm0302-194", "volume": "8", "author": "JL Hillebrands", "year": "2002", "unstructured": "Hillebrands JL, Klatter FA, van Dijk WD, Rozing J (2002) Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 8 (3): 194\u2013195", "journal-title": "Nat Med"}, {"issue": "6", "key": "BFbjc2011169_CR13", "doi-asserted-by": "publisher", "first-page": "e11084", "DOI": "10.1371/journal.pone.0011084", "volume": "5", "author": "N Imaizumi", "year": "2010", "unstructured": "Imaizumi N, Monnier Y, Hegi M, Mirimanoff RO, Ruegg C (2010) Radiotherapy suppresses angiogenesis in mice through TGF-betaRI/ALK5-dependent inhibition of endothelial cell sprouting. PLoS One 5 (6): e11084", "journal-title": "PLoS One"}, {"issue": "5", "key": "BFbjc2011169_CR14", "doi-asserted-by": "publisher", "first-page": "557", "DOI": "10.1038/nm1400", "volume": "12", "author": "DK Jin", "year": "2006", "unstructured": "Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, Dunn A, Salari H, Werb Z, Hackett NR, Crystal RG, Lyden D, Rafii S (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12 (5): 557\u2013567", "journal-title": "Nat Med"}, {"issue": "3", "key": "BFbjc2011169_CR15", "doi-asserted-by": "publisher", "first-page": "694", "DOI": "10.1172/JCI40283", "volume": "120", "author": "M Kioi", "year": "2010", "unstructured": "Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM (2010) Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 120 (3): 694\u2013705", "journal-title": "J Clin Invest"}, {"issue": "2", "key": "BFbjc2011169_CR16", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1172/JCI17902", "volume": "112", "author": "O Kollet", "year": "2003", "unstructured": "Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Thung SN, Dabeva MD, Kahn J, Spiegel A, Dar A, Samira S, Goichberg P, Kalinkovich A, Arenzana-Seisdedos F, Nagler A, Hardan I, Revel M, Shafritz DA, Lapidot T (2003) HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 112 (2): 160\u2013169", "journal-title": "J Clin Invest"}, {"issue": "14", "key": "BFbjc2011169_CR17", "doi-asserted-by": "publisher", "first-page": "5679", "DOI": "10.1158/0008-5472.CAN-09-4446", "volume": "70", "author": "SV Kozin", "year": "2010", "unstructured": "Kozin SV, Kamoun WS, Huang Y, Dawson MR, Jain RK, Duda DG (2010) Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation. Cancer Res 70 (14): 5679\u20135685", "journal-title": "Cancer Res"}, {"issue": "1", "key": "BFbjc2011169_CR18", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1007/s11060-009-0105-0", "volume": "99", "author": "Y Liu", "year": "2010", "unstructured": "Liu Y, Carson-Walter EB, Cooper A, Winans BN, Johnson MD, Walter KA (2010) Vascular gene expression patterns are conserved in primary and metastatic brain tumors. J Neurooncol 99 (1): 13\u201324", "journal-title": "J Neurooncol"}, {"key": "BFbjc2011169_CR19", "doi-asserted-by": "publisher", "first-page": "130", "DOI": "10.1016/j.ijrobp.2009.10.048", "volume": "79", "author": "MW McDonald", "year": "2010", "unstructured": "McDonald MW, Shu HK, Curran Jr WJ, Crocker IR (2010) Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys 79: 130\u2013136", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "40", "key": "BFbjc2011169_CR20", "doi-asserted-by": "publisher", "first-page": "15735", "DOI": "10.1073/pnas.0610444104", "volume": "104", "author": "Z Miao", "year": "2007", "unstructured": "Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ (2007) CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104 (40): 15735\u201315740", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "3", "key": "BFbjc2011169_CR21", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1016/j.radonc.2010.08.020", "volume": "97", "author": "G Minniti", "year": "2010", "unstructured": "Minniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A, Lanzetta G, Scarpino S, Arcella A, Enrici RM (2010) Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 97 (3): 377\u2013381", "journal-title": "Radiother Oncol"}, {"issue": "6824", "key": "BFbjc2011169_CR22", "doi-asserted-by": "publisher", "first-page": "50", "DOI": "10.1038/35065016", "volume": "410", "author": "A Muller", "year": "2001", "unstructured": "Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (6824): 50\u201356", "journal-title": "Nature"}, {"issue": "3", "key": "BFbjc2011169_CR23", "doi-asserted-by": "publisher", "first-page": "179", "DOI": "10.1006/smim.1998.0128", "volume": "10", "author": "T Nagasawa", "year": "1998", "unstructured": "Nagasawa T, Tachibana K, Kishimoto T (1998) A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin Immunol 10 (3): 179\u2013185", "journal-title": "Semin Immunol"}, {"issue": "3", "key": "BFbjc2011169_CR24", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1016/j.cell.2005.02.034", "volume": "121", "author": "A Orimo", "year": "2005", "unstructured": "Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121 (3): 335\u2013348", "journal-title": "Cell"}, {"issue": "18", "key": "BFbjc2011169_CR25", "doi-asserted-by": "publisher", "first-page": "6620", "DOI": "10.1073/pnas.0710516105", "volume": "105", "author": "S Purhonen", "year": "2008", "unstructured": "Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, Alitalo K, Weissman IL, Salven P (2008) Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 105 (18): 6620\u20136625", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "3", "key": "BFbjc2011169_CR26", "doi-asserted-by": "publisher", "first-page": "363", "DOI": "10.1634/stemcells.21-3-363", "volume": "21", "author": "MZ Ratajczak", "year": "2003", "unstructured": "Ratajczak MZ, Majka M, Kucia M, Drukala J, Pietrzkowski Z, Peiper S, Janowska-Wieczorek A (2003) Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 21 (3): 363\u2013371", "journal-title": "Stem Cells"}, {"issue": "22", "key": "BFbjc2011169_CR27", "doi-asserted-by": "publisher", "first-page": "6765", "DOI": "10.1158/1078-0432.CCR-06-1372", "volume": "12", "author": "N Redjal", "year": "2006", "unstructured": "Redjal N, Chan JA, Segal RA, Kung AL (2006) CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res 12 (22): 6765\u20136771", "journal-title": "Clin Cancer Res"}, {"issue": "7325", "key": "BFbjc2011169_CR28", "doi-asserted-by": "publisher", "first-page": "824", "DOI": "10.1038/nature09557", "volume": "468", "author": "L Ricci-Vitiani", "year": "2010", "unstructured": "Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T, Maira G, Parati EA, Stassi G, Larocca LM, De Maria R (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468 (7325): 824\u2013828", "journal-title": "Nature"}, {"issue": "1", "key": "BFbjc2011169_CR29", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/j.neuron.2010.12.006", "volume": "69", "author": "JA Sanchez-Alcaniz", "year": "2011", "unstructured": "Sanchez-Alcaniz JA, Haege S, Mueller W, Pla R, Mackay F, Schulz S, Lopez-Bendito G, Stumm R, Marin O (2011) Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 69 (1): 77\u201390", "journal-title": "Neuron"}, {"issue": "2", "key": "BFbjc2011169_CR30", "doi-asserted-by": "publisher", "first-page": "318", "DOI": "10.1359/JBMR.041109", "volume": "20", "author": "YX Sun", "year": "2005", "unstructured": "Sun YX, Schneider A, Jung Y, Wang J, Dai J, Cook K, Osman NI, Koh-Paige AJ, Shim H, Pienta KJ, Keller ET, McCauley LK, Taichman RS (2005) Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res 20 (2): 318\u2013329", "journal-title": "J Bone Miner Res"}, {"issue": "6685", "key": "BFbjc2011169_CR31", "doi-asserted-by": "publisher", "first-page": "591", "DOI": "10.1038/31261", "volume": "393", "author": "K Tachibana", "year": "1998", "unstructured": "Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393 (6685): 591\u2013594", "journal-title": "Nature"}, {"issue": "2", "key": "BFbjc2011169_CR32", "first-page": "905", "volume": "159", "author": "S Tanabe", "year": "1997", "unstructured": "Tanabe S, Heesen M, Yoshizawa I, Berman MA, Luo Y, Bleul CC, Springer TA, Okuda K, Gerard N, Dorf ME (1997) Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol 159 (2): 905\u2013911", "journal-title": "J Immunol"}, {"issue": "5121", "key": "BFbjc2011169_CR33", "doi-asserted-by": "publisher", "first-page": "600", "DOI": "10.1126/science.8342023", "volume": "261", "author": "K Tashiro", "year": "1993", "unstructured": "Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T (1993) Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261(5121): 600\u2013603", "journal-title": "Science"}, {"issue": "3", "key": "BFbjc2011169_CR34", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1084/jem.192.3.313", "volume": "192", "author": "B Tilton", "year": "2000", "unstructured": "Tilton B, Ho L, Oberlin E, Loetscher P, Baleux F, Clark-Lewis I, Thelen M (2000) Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med 192 (3): 313\u2013324", "journal-title": "J Exp Med"}, {"issue": "5", "key": "BFbjc2011169_CR35", "doi-asserted-by": "publisher", "first-page": "2040", "DOI": "10.1158/0008-5472.CAN-06-2877", "volume": "67", "author": "T Udagawa", "year": "2007", "unstructured": "Udagawa T, Birsner AE, Wood M, D\u2019Amato RJ (2007) Chronic suppression of angiogenesis following radiation exposure is independent of hematopoietic reconstitution. Cancer Res 67 (5): 2040\u20132045", "journal-title": "Cancer Res"}, {"issue": "51", "key": "BFbjc2011169_CR36", "doi-asserted-by": "publisher", "first-page": "49481", "DOI": "10.1074/jbc.M206222200", "volume": "277", "author": "Y Zhou", "year": "2002", "unstructured": "Zhou Y, Larsen PH, Hao C, Yong VW (2002) CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277 (51): 49481\u201349487", "journal-title": "J Biol Chem"}], "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc2011169.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc2011169", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc2011169.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 9]], "date-time": "2019-05-09T09:25:18Z", "timestamp": 1557393918000}, "score": 20.940859, "issued": {"date-parts": [[2011, 5, 17]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2011, 6]]}, "issue": "12"}, "alternative-id": ["BFbjc2011169"], "URL": "http://dx.doi.org/10.1038/bjc.2011.169", "relation": {"cites": []}, "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:13:25Z", "timestamp": 1574108005157}, "reference-count": 32, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2000, 4, 1]], "date-time": "2000-04-01T00:00:00Z", "timestamp": 954547200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Medicine Today"], "published-print": {"date-parts": [[2000, 4]]}, "DOI": "10.1016/s1357-4310(00)01677-4", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T02:08:35Z", "timestamp": 1027649315000}, "page": "157-162", "source": "Crossref", "is-referenced-by-count": 213, "title": ["Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies"], "prefix": "10.1016", "volume": "6", "author": [{"given": "J.Martin", "family": "Brown", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Molecular Medicine Today"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1357431000016774?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1357431000016774?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T00:58:07Z", "timestamp": 1555289887000}, "score": 20.93895, "issued": {"date-parts": [[2000, 4]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[2000, 4]]}, "issue": "4"}, "alternative-id": ["S1357431000016774"], "URL": "http://dx.doi.org/10.1016/s1357-4310(00)01677-4", "ISSN": ["1357-4310"], "issn-type": [{"value": "1357-4310", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:38Z", "timestamp": 1574489018442}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "7", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1996, 10, 1]], "date-time": "1996-10-01T00:00:00Z", "timestamp": 844128000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1996, 10]]}, "DOI": "10.1038/bjc.1996.505", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:41:17Z", "timestamp": 1295005277000}, "page": "1148-1151", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Birth characteristics and risk of Wilms' tumour: a nationwide prospective study in Norway"], "prefix": "10.1038", "volume": "74", "author": [{"given": "JM", "family": "Heuch", "sequence": "first", "affiliation": []}, {"given": "I", "family": "Heuch", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Kv\u00e5le", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc1996505.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1996505", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc1996505.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 15]], "date-time": "2019-03-15T16:37:54Z", "timestamp": 1552667874000}, "score": 20.877209, "issued": {"date-parts": [[1996, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 10]]}, "issue": "7"}, "alternative-id": ["BFbjc1996505"], "URL": "http://dx.doi.org/10.1038/bjc.1996.505", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T16:38:20Z", "timestamp": 1574786300250}, "reference-count": 97, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 4, 16]], "date-time": "2016-04-16T00:00:00Z", "timestamp": 1460764800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Curr Colorectal Cancer Rep"], "published-print": {"date-parts": [[2016, 6]]}, "DOI": "10.1007/s11888-016-0319-4", "type": "journal-article", "created": {"date-parts": [[2016, 4, 16]], "date-time": "2016-04-16T09:24:39Z", "timestamp": 1460798679000}, "page": "130-140", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Extramural Venous Invasion (EMVI) and Tumour Regression Grading (TRG) as Potential Prognostic Factors for Risk Stratification and Treatment Decision in Rectal Cancer"], "prefix": "10.1007", "volume": "12", "author": [{"given": "Francesco", "family": "Sclafani", "sequence": "first", "affiliation": []}, {"given": "Gina", "family": "Brown", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2016, 4, 16]]}, "reference": [{"issue": "4", "key": "319_CR1", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1001/jamaoncol.2015.0735", "volume": "1", "author": "C Fitzmaurice", "year": "2015", "unstructured": "Fitzmaurice C, Dicker D, Pain A, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505\u201327.", "journal-title": "JAMA Oncol"}, {"issue": "3", "key": "319_CR2", "first-page": "277", "volume": "22", "author": "RJ Heald", "year": "1979", "unstructured": "Heald RJ. A new approach to rectal cancer. Br J Hosp Med. 1979;22(3):277\u201381.", "journal-title": "Br J Hosp Med"}, {"issue": "9666", "key": "319_CR3", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1016/S0140-6736(09)60485-2", "volume": "373", "author": "P Quirke", "year": "2009", "unstructured": "Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients operated with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTGCO16 randomised clinical trial. Lancet. 2009;373(9666):821\u20138.", "journal-title": "Lancet"}, {"issue": "9", "key": "319_CR4", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1056/NEJMoa010580", "volume": "345", "author": "E Kapiteijn", "year": "2001", "unstructured": "Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638\u201346.", "journal-title": "N Engl J Med"}, {"issue": "17", "key": "319_CR5", "doi-asserted-by": "crossref", "first-page": "1731", "DOI": "10.1056/NEJMoa040694", "volume": "351", "author": "R Sauer", "year": "2004", "unstructured": "Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731\u201340.", "journal-title": "N Engl J Med"}, {"issue": "9", "key": "319_CR6", "doi-asserted-by": "crossref", "first-page": "1847", "DOI": "10.1200/JCO.2005.05.256", "volume": "23", "author": "CA Marijnen", "year": "2005", "unstructured": "Marijnen CA, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2005;23(9):1847\u201358.", "journal-title": "J Clin Oncol"}, {"issue": "25", "key": "319_CR7", "doi-asserted-by": "crossref", "first-page": "6199", "DOI": "10.1200/JCO.2005.14.779", "volume": "23", "author": "KC Peeters", "year": "2005", "unstructured": "Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients\u2014a Dutch Colorectal Cancer Group Study. J Clin Oncol. 2005;23(25):6199\u2013206.", "journal-title": "J Clin Oncol"}, {"issue": "24", "key": "319_CR8", "doi-asserted-by": "crossref", "first-page": "8697", "DOI": "10.1200/JCO.2005.02.9017", "volume": "23", "author": "H Birgisson", "year": "2005", "unstructured": "Birgisson H, P\u00e5hlman L, Gunnarsson U, et al. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol. 2005;23(24):8697\u2013705.", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "319_CR9", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1016/j.ijrobp.2010.07.007", "volume": "81", "author": "M Br\u00e6ndengen", "year": "2011", "unstructured": "Br\u00e6ndengen M, Tveit KM, Bruheim K, et al. Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study. Int J Radiat Oncol Biol Phys. 2011;81(4):1017\u201324.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "319_CR10", "first-page": "CD004323", "volume": "12", "author": "J Pachler", "year": "2012", "unstructured": "Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. 2012;12:CD004323.", "journal-title": "Cochrane Database Syst Rev"}, {"issue": "1", "key": "319_CR11", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1038/nrurol.2010.206", "volume": "8", "author": "MM Lange", "year": "2011", "unstructured": "Lange MM, van de Velde CJ. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol. 2011;8(1):51\u20137.", "journal-title": "Nat Rev Urol"}, {"issue": "5", "key": "319_CR12", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1016/j.canep.2015.07.009", "volume": "39", "author": "KM Augestad", "year": "2015", "unstructured": "Augestad KM, Bakaki PM, Rose J, et al. Metastatic spread pattern after curative colorectal cancer surgery. A retrospective, longitudinal analysis. Cancer Epidemiol. 2015;39(5):734\u201344.", "journal-title": "Cancer Epidemiol"}, {"issue": "10", "key": "319_CR13", "doi-asserted-by": "crossref", "first-page": "2311", "DOI": "10.1016/j.ejca.2013.03.006", "volume": "49", "author": "SM Engelen", "year": "2013", "unstructured": "Engelen SM, Maas M, Lahaye MJ, et al. Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer. 2013;49(10):2311\u201320.", "journal-title": "Eur J Cancer"}, {"issue": "4", "key": "319_CR14", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1097/SLA.0b013e31820b8d52", "volume": "253", "author": "FG Taylor", "year": "2011", "unstructured": "Taylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253(4):711\u20139.", "journal-title": "Ann Surg"}, {"issue": "10", "key": "319_CR15", "doi-asserted-by": "crossref", "first-page": "1109", "DOI": "10.1097/DCR.0b013e3182a25c4e", "volume": "56", "author": "A Habr-Gama", "year": "2013", "unstructured": "Habr-Gama A, Sabbaga J, Gama-Rodrigues J, et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum. 2013;56(10):1109\u201317.", "journal-title": "Dis Colon Rectum"}, {"issue": "6", "key": "319_CR16", "doi-asserted-by": "crossref", "first-page": "513", "DOI": "10.1200/JCO.2013.51.7904", "volume": "32", "author": "D Schrag", "year": "2014", "unstructured": "Schrag D, Weiser MR, Goodman KA, et al. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol. 2014;32(6):513\u20138.", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "319_CR17", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1016/S1470-2045(09)70381-X", "volume": "11", "author": "YJ Chua", "year": "2010", "unstructured": "Chua YJ, Barbachano Y, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol. 2010;11(3):241\u20138.", "journal-title": "Lancet Oncol"}, {"issue": "14", "key": "319_CR18", "doi-asserted-by": "crossref", "first-page": "1620", "DOI": "10.1200/JCO.2011.39.6036", "volume": "30", "author": "A Dewdney", "year": "2012", "unstructured": "Dewdney A, Cunningham D, Tabernero J, et al. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). J Clin Oncol. 2012;30(14):1620\u20137.", "journal-title": "J Clin Oncol"}, {"key": "319_CR19", "unstructured": "Sclafani F, Gonzalez D, Cunningham D, et al. TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial. J Natl Cancer Inst. 2014;106(7).", "DOI": "10.1093/jnci/dju121", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "319_CR20", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1002/path.1711500308", "volume": "150", "author": "L Weiss", "year": "1986", "unstructured": "Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol. 1986;150(3):195\u2013203.", "journal-title": "J Pathol"}, {"issue": "5", "key": "319_CR21", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1136/jcp.34.5.509", "volume": "34", "author": "WK Blenkinsopp", "year": "1981", "unstructured": "Blenkinsopp WK, Stewart-Brown S, Blesovsky L, et al. Histopathology reporting in large bowel cancer. J Clin Pathol. 1981;34(5):509\u201313.", "journal-title": "J Clin Pathol"}, {"issue": "Suppl 6", "key": "319_CR22", "doi-asserted-by": "crossref", "first-page": "vi64", "DOI": "10.1093/annonc/mdt354", "volume": "24", "author": "R Labianca", "year": "2013", "unstructured": "Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi64\u201372.", "journal-title": "Ann Oncol"}, {"key": "319_CR23", "unstructured": "NCCN Guidelines Version 3.2015 Colon Cancer. Available at: http://www.nccn.org"}, {"issue": "9604", "key": "319_CR24", "doi-asserted-by": "crossref", "first-page": "2020", "DOI": "10.1016/S0140-6736(07)61866-2", "volume": "370", "author": "R Gray", "year": "2007", "unstructured": "QUASAR Collaborative Group, Gray R, Barnwell J, McConkey C, et al. QUASAR: a randomised study of adjuvant chemotherapy versus observation including 3239 colorectal cancer patients. Lancet. 2007;370(9604):2020\u20139.", "journal-title": "Lancet"}, {"issue": "6", "key": "319_CR25", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1002/bjs.1800670619", "volume": "67", "author": "IC Talbot", "year": "1980", "unstructured": "Talbot IC, Ritchie S, Leighton MH, et al. The clinical significance of invasion of veins by rectal cancer. Br J Surg. 1980;67(6):439\u201342. One of the first studies to demonstrate that tumour vascular invasion within the resection specimens is associated with poor prognosis of rectal cancer.", "journal-title": "Br J Surg"}, {"issue": "9", "key": "319_CR26", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1007/BF02552975", "volume": "26", "author": "JB Knudsen", "year": "1983", "unstructured": "Knudsen JB, Nilsson T, Sprechler M, et al. Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis Colon Rectum. 1983;26(9):613\u20137.", "journal-title": "Dis Colon Rectum"}, {"issue": "1", "key": "319_CR27", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1006/jsre.2001.6312", "volume": "103", "author": "K G\u00fcnther", "year": "2002", "unstructured": "G\u00fcnther K, Dworak O, Remke S, et al. Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res. 2002;103(1):68\u201378.", "journal-title": "J Surg Res"}, {"issue": "25", "key": "319_CR28", "doi-asserted-by": "crossref", "first-page": "4078", "DOI": "10.1200/JCO.2006.06.2968", "volume": "24", "author": "A Nissan", "year": "2006", "unstructured": "Nissan A, Stojadinovic A, Shia J, et al. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol. 2006;24(25):4078\u201384.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "319_CR29", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/0002-9610(81)90004-0", "volume": "141", "author": "IC Talbot", "year": "1981", "unstructured": "Talbot IC, Ritchie S, Leighton MH, et al. Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg. 1981;141(1):15\u20137.", "journal-title": "Am J Surg"}, {"issue": "8405", "key": "319_CR30", "doi-asserted-by": "crossref", "first-page": "733", "DOI": "10.1016/S0140-6736(84)92636-9", "volume": "2", "author": "LS Freedman", "year": "1984", "unstructured": "Freedman LS, Macaskill P, Smith AN. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet. 1984;2(8405):733\u20136.", "journal-title": "Lancet"}, {"issue": "5", "key": "319_CR31", "doi-asserted-by": "crossref", "first-page": "498", "DOI": "10.1016/0046-8177(94)90122-8", "volume": "25", "author": "JC Harrison", "year": "1994", "unstructured": "Harrison JC, Dean PJ, El-Zeky F, et al. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum Pathol. 1994;25(5):498\u2013505.", "journal-title": "Hum Pathol"}, {"issue": "4", "key": "319_CR32", "doi-asserted-by": "crossref", "first-page": "858", "DOI": "10.1093/annonc/mdu029", "volume": "25", "author": "M Chand", "year": "2014", "unstructured": "Chand M, Bhangu A, Wotherspoon A, et al. EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy. Ann Oncol. 2014;25(4):858\u201363.", "journal-title": "Ann Oncol"}, {"issue": "3", "key": "319_CR33", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1002/bjs.4034", "volume": "90", "author": "G Brown", "year": "2003", "unstructured": "Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90(3):355\u201364. First study to demonstrate that invasion of large extramural veins by rectal cancer is detectable by MRI and can predict tumour vascular invasion within the resection specimens.", "journal-title": "Br J Surg"}, {"issue": "2", "key": "319_CR34", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1002/bjs.5917", "volume": "95", "author": "NJ Smith", "year": "2008", "unstructured": "Smith NJ, Barbachano Y, Norman AR, et al. Prognostic significance of magnetic resonance imaging detected extramural vascular invasion in rectal cancer. Br J Surg. 2008;95(2):229\u201336. Retrospective study showing that mrEMVI is a predictive factor of outcome in rectal cancer.", "journal-title": "Br J Surg"}, {"issue": "5", "key": "319_CR35", "doi-asserted-by": "crossref", "first-page": "1347", "DOI": "10.1007/s00330-014-3527-9", "volume": "25", "author": "B Sohn", "year": "2015", "unstructured": "Sohn B, Lim JS, Kim H, et al. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol. 2015;25(5):1347\u201355. Retrospective study showing that mrEMVI is associated with an increased risk of distant metastases from rectal cancer.", "journal-title": "Eur Radiol"}, {"key": "319_CR36", "first-page": "267", "volume": "2", "author": "DM Koh", "year": "2008", "unstructured": "Koh DM, Smith NJ, Swift RI, et al. The relationship between MR demonstration of extramural venous invasion and nodal disease in rectal cancer. Clin Med Oncol. 2008;2:267\u201373.", "journal-title": "Clin Med Oncol"}, {"issue": "7572", "key": "319_CR37", "doi-asserted-by": "crossref", "first-page": "779", "DOI": "10.1136/bmj.38937.646400.55", "volume": "333", "author": "MERCURY Study Group", "year": "2006", "unstructured": "MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333(7572):779.", "journal-title": "BMJ"}, {"issue": "1", "key": "319_CR38", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1148/radiol.2431051825", "volume": "243", "author": "MERCURY Study Group", "year": "2007", "unstructured": "MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology. 2007;243(1):132\u20139.", "journal-title": "Radiology"}, {"issue": "6", "key": "319_CR39", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1016/j.crad.2014.01.010", "volume": "69", "author": "WG Bugg", "year": "2014", "unstructured": "Bugg WG, Andreou AK, Biswas D, et al. The prognostic significance of MRI-detected extramural venous invasion in rectal carcinoma. Clin Radiol. 2014;69(6):619\u201323.", "journal-title": "Clin Radiol"}, {"issue": "3", "key": "319_CR40", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1016/j.ijrobp.2013.06.2052", "volume": "87", "author": "SK Yu", "year": "2013", "unstructured": "Yu SK, Tait D, Chau I, et al. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy? Int J Radiat Oncol Biol Phys. 2013;87(3):505\u201311.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "1", "key": "319_CR41", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1038/bjc.2013.603", "volume": "110", "author": "M Chand", "year": "2014", "unstructured": "Chand M, Swift RI, Tekkis PP, et al. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer. 2014;110(1):19\u201325.", "journal-title": "Br J Cancer"}, {"issue": "16", "key": "319_CR42", "doi-asserted-by": "crossref", "first-page": "1926", "DOI": "10.1200/JCO.2011.40.1836", "volume": "30", "author": "R Sauer", "year": "2012", "unstructured": "Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-yp of 11 years. J Clin Oncol. 2012;30(16):1926\u201333.", "journal-title": "J Clin Oncol"}, {"issue": "9666", "key": "319_CR43", "doi-asserted-by": "crossref", "first-page": "811", "DOI": "10.1016/S0140-6736(09)60484-0", "volume": "373", "author": "D Sebag-Montefiore", "year": "2009", "unstructured": "Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373(9666):811\u201320.", "journal-title": "Lancet"}, {"issue": "15", "key": "319_CR44", "doi-asserted-by": "crossref", "first-page": "1770", "DOI": "10.1200/JCO.2011.39.7901", "volume": "30", "author": "IJ Park", "year": "2012", "unstructured": "Park IJ, You YN, Agarwal A, et al. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol. 2012;30(15):1770\u20136.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "319_CR45", "doi-asserted-by": "crossref", "first-page": "1005", "DOI": "10.1016/j.ijrobp.2015.09.008", "volume": "93", "author": "MH Martens", "year": "2015", "unstructured": "Martens MH, van Heeswijk MM, van den Broek JJ, et al. Prospective, multicenter validation study of magnetic resonance volumetry for response assessment after preoperative chemoradiation in rectal cancer: can the results in the literature be reproduced? Int J Radiat Oncol Biol Phys. 2015;93(5):1005\u201314.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "10", "key": "319_CR46", "doi-asserted-by": "crossref", "first-page": "867", "DOI": "10.1136/jclinpath-2012-200958", "volume": "65", "author": "TP MacGregor", "year": "2012", "unstructured": "MacGregor TP, Maughan TS, Sharma RA. Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now. J Clin Pathol. 2012;65(10):867\u201371.", "journal-title": "J Clin Pathol"}, {"issue": "1", "key": "319_CR47", "doi-asserted-by": "crossref", "first-page": "204", "DOI": "10.1016/j.ijrobp.2006.08.020", "volume": "67", "author": "NK Kim", "year": "2007", "unstructured": "Kim NK, Baik SH, Min BS, et al. A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation. Int J Radiat Oncol Biol Phys. 2007;67(1):204\u201310.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "11", "key": "319_CR48", "doi-asserted-by": "crossref", "first-page": "3598", "DOI": "10.1245/s10434-014-3753-z", "volume": "21", "author": "S Memon", "year": "2014", "unstructured": "Memon S, Lynch AC, Akhurst T, et al. Systematic review of FDG-PET prediction of complete pathological response and survival in rectal cancer. Ann Surg Oncol. 2014;21(11):3598\u2013607.", "journal-title": "Ann Surg Oncol"}, {"issue": "8", "key": "319_CR49", "doi-asserted-by": "crossref", "first-page": "1239", "DOI": "10.1093/annonc/mdl173", "volume": "17", "author": "R Glynne-Jones", "year": "2006", "unstructured": "Glynne-Jones R, Mawdsley S, Pearce T, et al. Alternative clinical end points in rectal cancer--are we getting closer? Ann Oncol. 2006;17(8):1239\u201348.", "journal-title": "Ann Oncol"}, {"key": "319_CR50", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1007/978-3-642-31629-6_1", "volume": "196", "author": "C Fernandez-Martos", "year": "2012", "unstructured": "Fernandez-Martos C, Guerrero A, Minsky B. Clinically relevant study end points in rectal cancer. Recent Results Cancer Res. 2012;196:3\u201319.", "journal-title": "Recent Results Cancer Res"}, {"issue": "7", "key": "319_CR51", "doi-asserted-by": "crossref", "first-page": "918", "DOI": "10.1002/bjs.8702", "volume": "99", "author": "ST Martin", "year": "2012", "unstructured": "Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99(7):918\u201328.", "journal-title": "Br J Surg"}, {"issue": "9", "key": "319_CR52", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1016/S1470-2045(10)70172-8", "volume": "11", "author": "M Maas", "year": "2010", "unstructured": "Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835\u201344.", "journal-title": "Lancet Oncol"}, {"issue": "1", "key": "319_CR53", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1007/s003840050072", "volume": "12", "author": "O Dworak", "year": "1997", "unstructured": "Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1):19\u201323. First study to show that in rectal cancer it is feasible to classify response to pre-operative (chemo)radiotherapy by assessing the degree of tumour regression within resection specimens.", "journal-title": "Int J Colorectal Dis"}, {"issue": "11", "key": "319_CR54", "doi-asserted-by": "crossref", "first-page": "2680", "DOI": "10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C", "volume": "73", "author": "AM Mandard", "year": "1994", "unstructured": "Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73(11):2680\u20136.", "journal-title": "Cancer"}, {"issue": "15", "key": "319_CR55", "doi-asserted-by": "crossref", "first-page": "1554", "DOI": "10.1200/JCO.2013.54.3769", "volume": "32", "author": "E Fokas", "year": "2014", "unstructured": "Fokas E, Liersch T, Fietkau R, et al. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol. 2014;32(15):1554\u201362. Largest study to demonstrate that ypTRG after chemoradiotherapy in rectal cancer is an independent predictive factor for disease-free survival and distant metastases.", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "319_CR56", "doi-asserted-by": "crossref", "first-page": "752", "DOI": "10.1016/j.ijrobp.2004.11.017", "volume": "62", "author": "FM Vecchio", "year": "2005", "unstructured": "Vecchio FM, Valentini V, Minsky BD, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys. 2005;62(3):752\u201360.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "5", "key": "319_CR57", "doi-asserted-by": "crossref", "first-page": "505", "DOI": "10.1136/jcp.2005.031609", "volume": "59", "author": "E Benzoni", "year": "2006", "unstructured": "Benzoni E, Intersimone D, Terrosu G, et al. Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer. J Clin Pathol. 2006;59(5):505\u201312.", "journal-title": "J Clin Pathol"}, {"issue": "1", "key": "319_CR58", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1097/DCR.0000000000000266", "volume": "58", "author": "AG Mace", "year": "2015", "unstructured": "Mace AG, Pai RK, Stocchi L, et al. American Joint Committee on Cancer and College of American Pathologists regression grade: a new prognostic factor in rectal cancer. Dis Colon Rectum. 2015;58(1):32\u201344.", "journal-title": "Dis Colon Rectum"}, {"issue": "1", "key": "319_CR59", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1111/j.1365-2559.2011.03888.x", "volume": "59", "author": "J Lindebjerg", "year": "2011", "unstructured": "Lindebjerg J, Hansborg N, Ploen J, et al. Factors influencing reproducibility of tumour regression grading after high-dose chemoradiation of locally advanced rectal cancer. Histopathology. 2011;59(1):18\u201321.", "journal-title": "Histopathology"}, {"issue": "2", "key": "319_CR60", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1007/s00428-012-1193-3", "volume": "460", "author": "R Chetty", "year": "2012", "unstructured": "Chetty R, Gill P, Govender D, et al. A multi-centre pathologist survey on pathological processing and regression grading of colorectal cancer resection specimens treated by neoadjuvant chemoradiation. Virchows Arch. 2012;460(2):151\u20135.", "journal-title": "Virchows Arch"}, {"issue": "11", "key": "319_CR61", "doi-asserted-by": "crossref", "first-page": "1917", "DOI": "10.1016/j.humpath.2012.01.020", "volume": "43", "author": "R Chetty", "year": "2012", "unstructured": "Chetty R, Gill P, Govender D, et al. International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems. Hum Pathol. 2012;43(11):1917\u201323.", "journal-title": "Hum Pathol"}, {"key": "319_CR62", "doi-asserted-by": "crossref", "first-page": "1051", "DOI": "10.1007/s10350-004-6359-x", "volume": "45", "author": "JM Wheeler", "year": "2002", "unstructured": "Wheeler JM, Warren BF, Mortensen NJ, et al. Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis Colon Rectum. 2002;45:1051\u20136.", "journal-title": "Dis Colon Rectum"}, {"issue": "2", "key": "319_CR63", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1111/j.1365-2559.2005.02176.x", "volume": "47", "author": "R Ryan", "year": "2005", "unstructured": "Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141\u20136.", "journal-title": "Histopathology"}, {"issue": "7", "key": "319_CR64", "doi-asserted-by": "crossref", "first-page": "645", "DOI": "10.1007/s00384-005-0061-x", "volume": "21", "author": "L Losi", "year": "2006", "unstructured": "Losi L, Luppi G, Gavioli M, et al. Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy. Int J Colorectal Dis. 2006;21(7):645\u201351.", "journal-title": "Int J Colorectal Dis"}, {"issue": "12", "key": "319_CR65", "doi-asserted-by": "crossref", "first-page": "3471", "DOI": "10.1245/s10434-008-0149-y", "volume": "15", "author": "D Beddy", "year": "2008", "unstructured": "Beddy D, Hyland JM, Winter DC, et al. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol. 2008;15(12):3471\u20137.", "journal-title": "Ann Surg Oncol"}, {"issue": "6", "key": "319_CR66", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1111/j.1463-1318.2007.01424.x", "volume": "10", "author": "J Suarez", "year": "2008", "unstructured": "Suarez J, Vera R, Bal\u00e9n E, et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis. 2008;10(6):563\u20138.", "journal-title": "Colorectal Dis"}, {"key": "319_CR67", "author": "S Edge", "year": "2010", "edition": "7", "unstructured": "Edge S, Fritz A, Byrd D, et al. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.", "volume-title": "AJCC Cancer Staging Manual"}, {"issue": "8", "key": "319_CR68", "doi-asserted-by": "crossref", "first-page": "1138", "DOI": "10.1016/j.ejca.2010.12.006", "volume": "47", "author": "AS Dhadda", "year": "2011", "unstructured": "Dhadda AS, Dickinson P, Zaitoun AM, et al. Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancer. Eur J Cancer. 2011;47(8):1138\u201345.", "journal-title": "Eur J Cancer"}, {"issue": "2", "key": "319_CR69", "doi-asserted-by": "crossref", "first-page": "130", "DOI": "10.1002/jso.22073", "volume": "105", "author": "P Roy", "year": "2012", "unstructured": "Roy P, Serra S, Kennedy E, et al. The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy. J Surg Oncol. 2012;105(2):130\u20134.", "journal-title": "J Surg Oncol"}, {"key": "319_CR70", "unstructured": "Trakarnsanga A, G\u00f6nen M, Shia J, et al. Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment. J Natl Cancer Inst. 2014;106(10).", "DOI": "10.1093/jnci/dju248", "doi-asserted-by": "crossref"}, {"issue": "8", "key": "319_CR71", "doi-asserted-by": "crossref", "first-page": "972", "DOI": "10.1002/bjs.9811", "volume": "102", "author": "D Pettersson", "year": "2015", "unstructured": "Pettersson D, L\u00f6rinc E, Holm T, et al. Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg. 2015;102(8):972\u20138.", "journal-title": "Br J Surg"}, {"issue": "4", "key": "319_CR72", "doi-asserted-by": "crossref", "first-page": "632", "DOI": "10.1007/DCR.0b013e3181a0a37e", "volume": "52", "author": "GV Salerno", "year": "2009", "unstructured": "Salerno GV, Daniels IR, Moran BJ, et al. Magnetic resonance imaging prediction of an involved surgical resection margin in low rectal cancer. Dis Colon Rectum. 2009;52(4):632\u20139. First study to propose an MRI-based classification system to assess the degree of tumour regression after neoadjuvant (chemo)radiotherapy in rectal cancer.", "journal-title": "Dis Colon Rectum"}, {"issue": "28", "key": "319_CR73", "doi-asserted-by": "crossref", "first-page": "3753", "DOI": "10.1200/JCO.2011.34.9068", "volume": "29", "author": "UB Patel", "year": "2011", "unstructured": "Patel UB, Taylor F, Blomqvist L, et al. Magnetic resonance imaging\u2013detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol. 2011;29(28):3753\u201360. First study in rectal cancer to demonstrate the prognostic role of tumour regression grade as assessed by MRI after neoadjuvant (chemo)radiotherapy.", "journal-title": "J Clin Oncol"}, {"issue": "6", "key": "319_CR74", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1016/S1470-2045(11)70097-3", "volume": "12", "author": "W Gijn Van", "year": "2011", "unstructured": "Van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575\u201382.", "journal-title": "Lancet Oncol"}, {"issue": "23", "key": "319_CR75", "doi-asserted-by": "crossref", "first-page": "2343", "DOI": "10.1056/NEJMoa032709", "volume": "350", "author": "T Andr\u00e9", "year": "2004", "unstructured": "Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343\u201351.", "journal-title": "N Engl J Med"}, {"issue": "16", "key": "319_CR76", "doi-asserted-by": "crossref", "first-page": "2198", "DOI": "10.1200/JCO.2006.08.2974", "volume": "25", "author": "JP Kuebler", "year": "2007", "unstructured": "Kuebler JP, Wieand HS, O\u2019Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol. 2007;25(16):2198\u2013204.", "journal-title": "J Clin Oncol"}, {"key": "319_CR77", "first-page": "CD004078", "volume": "3", "author": "SH Petersen", "year": "2012", "unstructured": "Petersen SH, Harling H, Kirkeby LT, et al. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev. 2012;3:CD004078.", "journal-title": "Cochrane Database Syst Rev"}, {"issue": "2", "key": "319_CR78", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1016/S1470-2045(13)70599-0", "volume": "15", "author": "JF Bosset", "year": "2014", "unstructured": "Bosset JF, Calais G, Mineur L, et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol. 2014;15(2):184\u201390.", "journal-title": "Lancet Oncol"}, {"issue": "2", "key": "319_CR79", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/j.radonc.2014.10.006", "volume": "113", "author": "A Sainato", "year": "2014", "unstructured": "Sainato A, Cernusco LNV, Valentini V, et al. No benefit of adjuvant fluorouracil leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): long term results of a randomized trial (I-CNR-RT). Radiother Oncol. 2014;113(2):223\u20139.", "journal-title": "Radiother Oncol"}, {"issue": "7", "key": "319_CR80", "doi-asserted-by": "crossref", "first-page": "1356", "DOI": "10.1093/annonc/mdu147", "volume": "25", "author": "R Glynne-Jones", "year": "2014", "unstructured": "Glynne-Jones R, Counsell N, Quirke P, et al. Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. Ann Oncol. 2014;25(7):1356\u201362.", "journal-title": "Ann Oncol"}, {"issue": "4", "key": "319_CR81", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1093/annonc/mdu560", "volume": "26", "author": "AJ Breugom", "year": "2015", "unstructured": "Breugom AJ, van Gijn W, Muller EW, et al. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. Ann Oncol. 2015;26(4):696\u2013701.", "journal-title": "Ann Oncol"}, {"issue": "2", "key": "319_CR82", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1016/S1470-2045(14)71199-4", "volume": "16", "author": "AJ Breugom", "year": "2015", "unstructured": "Breugom AJ, Swets M, Bosset JF, et al. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta analysis of individual patient data. Lancet Oncol. 2015;16(2):200\u20137.", "journal-title": "Lancet Oncol"}, {"issue": "1", "key": "319_CR83", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1002/ijc.29355", "volume": "137", "author": "M Maas", "year": "2015", "unstructured": "Maas M, Nelemans PJ, Valentini V, et al. Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection. Int J Cancer. 2015;137(1):212\u201320.", "journal-title": "Int J Cancer"}, {"issue": "28", "key": "319_CR84", "doi-asserted-by": "crossref", "first-page": "4379", "DOI": "10.1200/JCO.2007.11.9685", "volume": "25", "author": "L Collette", "year": "2007", "unstructured": "Collette L, Bosset JF, den Dulk M, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol. 2007;25(28):4379\u201386.", "journal-title": "J Clin Oncol"}, {"issue": "34", "key": "319_CR85", "doi-asserted-by": "crossref", "first-page": "8688", "DOI": "10.1200/JCO.2005.02.1329", "volume": "23", "author": "C R\u00f6del", "year": "2005", "unstructured": "R\u00f6del C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23(34):8688\u201396.", "journal-title": "J Clin Oncol"}, {"issue": "Suppl 6", "key": "319_CR86", "doi-asserted-by": "crossref", "first-page": "vi81-8", "DOI": "10.1093/annonc/mdt240", "volume": "24", "author": "B Glimelius", "year": "2013", "unstructured": "Glimelius B, Tiret E, Cervantes A, et al. ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24 Suppl 6:vi81-8.", "journal-title": "Ann Oncol"}, {"issue": "5", "key": "319_CR87", "doi-asserted-by": "crossref", "first-page": "859", "DOI": "10.1200/JCO.2009.25.8541", "volume": "28", "author": "C Fern\u00e1ndez-Martos", "year": "2010", "unstructured": "Fern\u00e1ndez-Martos C, Pericay C, Aparicio J, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo C\u00e1ncer de Recto 3 Study. J Clin Oncol. 2010;28(5):859\u201365.", "journal-title": "J Clin Oncol"}, {"issue": "10", "key": "319_CR88", "doi-asserted-by": "crossref", "first-page": "2517", "DOI": "10.1093/annonc/mds010", "volume": "23", "author": "R Glynne-Jones", "year": "2012", "unstructured": "Glynne-Jones R, Anyamene N, Moran B, et al. Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation? Ann Oncol. 2012;23(10):2517\u201326.", "journal-title": "Ann Oncol"}, {"key": "319_CR89", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1186/1471-2407-13-279", "volume": "13", "author": "PJ Nilsson", "year": "2013", "unstructured": "Nilsson PJ, van Etten B, Hospers GA, et al. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. BMC Cancer. 2013;13:279.", "journal-title": "BMC Cancer"}, {"issue": "4", "key": "319_CR90", "first-page": "711", "volume": "240", "author": "A Habr-Gama", "year": "2004", "unstructured": "Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711\u20137.", "journal-title": "Ann Surg"}, {"issue": "15", "key": "319_CR91", "doi-asserted-by": "crossref", "first-page": "1537", "DOI": "10.1016/S1470-2045(15)00215-6", "volume": "16", "author": "J Garcia-Aguilar", "year": "2015", "unstructured": "Garcia-Aguilar J, Renfro LA, Chow OS, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015;16(15):1537\u201346.", "journal-title": "Lancet Oncol"}, {"issue": "1", "key": "319_CR92", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/j.clon.2008.10.011", "volume": "21", "author": "AS Dhadda", "year": "2009", "unstructured": "Dhadda AS, Zaitoun AM, Bessell EM. Regression of rectal cancer with radiotherapy with or without concurrent capecitabine\u2014optimising the timing of surgical resection. Clin Oncol. 2009;21(1):23\u201331.", "journal-title": "Clin Oncol"}, {"issue": "7", "key": "319_CR93", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1002/bjs.9112", "volume": "100", "author": "DA Sloothaak", "year": "2013", "unstructured": "Sloothaak DA, Geijsen DE, van Leersum NJ, et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2013;100(7):933\u20139.", "journal-title": "Br J Surg"}, {"issue": "2", "key": "319_CR94", "doi-asserted-by": "crossref", "first-page": "430", "DOI": "10.1016/j.jamcollsurg.2015.04.010", "volume": "221", "author": "CP Probst", "year": "2015", "unstructured": "Probst CP, Becerra AZ, Aquina CT, et al. Extended intervals after neoadjuvant therapy in locally advanced rectal cancer: the key to improved tumor response and potential organ preservation. J Am Coll Surg. 2015;221(2):430\u201340.", "journal-title": "J Am Coll Surg"}, {"key": "319_CR95", "unstructured": "Huntington CR, Boselli D, Symanowski J, et al. Optimal timing of surgical resection after radiation in locally advanced rectal adenocarcinoma: an analysis of the National Cancer Database. Ann Surg Oncol. 2015;Oct 29 [Epub ahead of print].", "DOI": "10.1245/s10434-015-4927-z", "doi-asserted-by": "crossref"}, {"issue": "14", "key": "319_CR96", "doi-asserted-by": "crossref", "first-page": "2243", "DOI": "10.2217/fon.14.127", "volume": "10", "author": "F Sclafani", "year": "2014", "unstructured": "Sclafani F, Cunningham D. Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer. Future Oncol. 2014;10(14):2243\u201357.", "journal-title": "Future Oncol"}, {"key": "319_CR97", "unstructured": "PROSPECT: chemotherapy alone or chemotherapy plus radiation therapy in treating patients with locally advanced rectal cancer undergoing surgery. Available at https://clinicaltrials.gov/ct2/show/NCT01515787"}], "container-title": ["Current Colorectal Cancer Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11888-016-0319-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s11888-016-0319-4/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11888-016-0319-4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 6]], "date-time": "2019-09-06T19:38:47Z", "timestamp": 1567798727000}, "score": 20.81353, "issued": {"date-parts": [[2016, 4, 16]]}, "references-count": 97, "journal-issue": {"published-print": {"date-parts": [[2016, 6]]}, "issue": "3"}, "alternative-id": ["319"], "URL": "http://dx.doi.org/10.1007/s11888-016-0319-4", "relation": {"cites": []}, "ISSN": ["1556-3790", "1556-3804"], "issn-type": [{"value": "1556-3790", "type": "print"}, {"value": "1556-3804", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T03:02:55Z", "timestamp": 1574305375043}, "reference-count": 46, "publisher": "Informa UK Limited", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["International Journal of Radiation Biology"], "published-print": {"date-parts": [[1994, 1]]}, "DOI": "10.1080/09553009414550131", "type": "journal-article", "created": {"date-parts": [[2007, 7, 7]], "date-time": "2007-07-07T08:17:36Z", "timestamp": 1183796256000}, "page": "95-102", "source": "Crossref", "is-referenced-by-count": 69, "title": ["Tumour Hypoxia: The Picture Has Changed in the 1990s"], "prefix": "10.1080", "volume": "65", "author": [{"given": "J.M.", "family": "Brown", "sequence": "first", "affiliation": []}, {"given": "A.J.", "family": "Giaccia", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7, 3]]}, "reference": [{"key": "CIT0001", "author": "Anderson G.R.", "volume": "264", "first-page": "14885", "year": "1989", "journal-title": "Journal of Biological Chemistry"}, {"key": "CIT0002", "author": "Berry R.J", "first-page": "141", "year": "1974", "volume-title": "The Biological and Clinical Basis of Radiosensitivity"}, {"key": "CIT0003", "author": "Brock W.A.", "volume": "56", "first-page": "751", "year": "1989", "journal-title": "International Journal of Radiation Biology", "DOI": "10.1080/09553008914552001", "doi-asserted-by": "crossref"}, {"key": "CIT0004", "author": "Brown J.M", "volume": "52", "first-page": "650", "year": "1979", "journal-title": "British Journal of Radiology", "DOI": "10.1259/0007-1285-52-620-650", "doi-asserted-by": "crossref"}, {"key": "CIT0005", "author": "Brown J.M", "volume": "10", "first-page": "425", "year": "1984", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(84)90063-4", "doi-asserted-by": "crossref"}, {"key": "CIT0006", "author": "Brown J.M.", "volume": "83", "first-page": "178", "year": "1991", "journal-title": "Journal of the National Cancer Institute", "DOI": "10.1093/jnci/83.3.178", "doi-asserted-by": "crossref"}, {"key": "CIT0007", "author": "Brown J.M.", "volume": "50", "first-page": "7745", "year": "1990", "journal-title": "Cancer Research"}, {"key": "CIT0008", "author": "Brown J.M.", "first-page": "807", "year": "1992", "volume-title": "Radiation Research a Twentieth Century Perspective"}, {"key": "CIT0009", "author": "Chaplin D.J.", "volume": "47", "first-page": "597", "year": "1987", "journal-title": "Cancer Research"}, {"key": "CIT0010", "author": "Datta R.", "volume": "31", "first-page": "8300", "year": "1992", "journal-title": "Biochemistry", "DOI": "10.1021/bi00150a025", "doi-asserted-by": "crossref"}, {"key": "CIT0011", "author": "Deacon J.", "volume": "2", "first-page": "317", "year": "1984", "journal-title": "Radiotherapy and Oncology", "DOI": "10.1016/S0167-8140(84)80074-2", "doi-asserted-by": "crossref"}, {"key": "CIT0013", "author": "Dorie M.J.", "volume": "53", "first-page": "4633", "year": "1993", "journal-title": "Cancer Research"}, {"key": "CIT0014", "author": "Dorie M.J.", "year": "1993", "journal-title": "International Journal of Radiation Oncology, Biology and Physics"}, {"key": "CIT0015", "author": "Fertil B.", "volume": "7", "first-page": "612", "year": "1981", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(81)90377-1", "doi-asserted-by": "crossref"}, {"key": "CIT0016", "author": "Gatenby R.A.", "volume": "14", "first-page": "831", "year": "1988", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(88)90002-8", "doi-asserted-by": "crossref"}, {"key": "CIT0017", "author": "Giaccia A.J.", "volume": "23", "first-page": "891", "year": "1992", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(92)90667-7", "doi-asserted-by": "crossref"}, {"key": "CIT0018", "author": "Goldberg M.A.", "volume": "242", "first-page": "1412", "year": "1988", "journal-title": "Science", "DOI": "10.1126/science.2849206", "doi-asserted-by": "crossref"}, {"key": "CIT0019", "author": "Graeber T.", "year": "1993", "journal-title": "Cell"}, {"key": "CIT0020", "author": "Grau C.", "volume": "13", "first-page": "301", "year": "1988", "journal-title": "Radiotherapy and Oncology", "DOI": "10.1016/0167-8140(88)90225-3", "doi-asserted-by": "crossref"}, {"key": "CIT0021", "author": "Hall E.J", "volume": "40", "first-page": "874", "year": "1967", "journal-title": "British Journal of Radiology", "DOI": "10.1259/0007-1285-40-479-874", "doi-asserted-by": "crossref"}, {"key": "CIT0022", "author": "Heacock C.S.", "volume": "62", "first-page": "217", "year": "1990", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1990.264", "doi-asserted-by": "crossref"}, {"key": "CIT0023", "author": "Hill R.P", "volume": "12", "first-page": "1049", "year": "1986", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(86)90223-3", "doi-asserted-by": "crossref"}, {"key": "CIT0024", "author": "Hockel M.", "volume": "26", "first-page": "45", "year": "1993", "journal-title": "Radiotherapy and Oncology", "DOI": "10.1016/0167-8140(93)90025-4", "doi-asserted-by": "crossref"}, {"key": "CIT0025", "author": "Hockel M.", "volume": "51", "first-page": "6098", "year": "1991", "journal-title": "Cancer Research"}, {"key": "CIT0026", "author": "Kaplan H.S", "volume": "43", "first-page": "460", "year": "1970", "journal-title": "Radiation Research", "DOI": "10.2307/3573049", "doi-asserted-by": "crossref"}, {"key": "CIT0027", "author": "Kennedy K.A", "volume": "2", "first-page": "181", "year": "1987", "journal-title": "Anticancer Drug Design"}, {"key": "CIT0028", "author": "Kim I.H.", "year": "1993", "journal-title": "International Journal of Radiation Oncology, Biology and Physics"}, {"key": "CIT0029", "author": "Koh W.-J.", "volume": "22", "first-page": "199", "year": "1992", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(92)91001-4", "doi-asserted-by": "crossref"}, {"key": "CIT0030", "author": "Koong A.", "year": "1993", "journal-title": "International Journal of Radiation Oncology, Biology and Physics"}, {"key": "CIT0031", "author": "Lowry C.V.", "volume": "10", "first-page": "5921", "year": "1990", "journal-title": "Molecular and Cellular Biology", "DOI": "10.1128/MCB.10.11.5921", "doi-asserted-by": "crossref"}, {"key": "CIT0032", "author": "Mueller-Klieser W.", "volume": "7", "first-page": "1397", "year": "1981", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(81)90036-5", "doi-asserted-by": "crossref"}, {"key": "CIT0033", "author": "Murphy B.J.", "volume": "64", "first-page": "69", "year": "1991", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1991.241", "doi-asserted-by": "crossref"}, {"key": "CIT0034", "author": "Overgaard J.", "volume": "12", "first-page": "515", "year": "1986", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(86)90058-1", "doi-asserted-by": "crossref"}, {"key": "CIT0035", "author": "Rofstad E.K.", "volume": "47", "first-page": "106", "year": "1987", "journal-title": "Cancer Research"}, {"key": "CIT0036", "author": "Roll D.E.", "volume": "103", "first-page": "141", "year": "1991", "journal-title": "Molecular and Cellular Biochemistry"}, {"key": "CIT0037", "author": "Sartorelli A.C", "volume": "48", "first-page": "775", "year": "1988", "journal-title": "Cancer Research"}, {"key": "CIT0038", "author": "Sciandra J.J.", "volume": "81", "first-page": "4843", "year": "1984", "journal-title": "Proceedings of the National Academy of Sciences, USA", "DOI": "10.1073/pnas.81.15.4843", "doi-asserted-by": "crossref"}, {"key": "CIT0039", "author": "Shweiki D.", "volume": "359", "first-page": "843", "year": "1992", "journal-title": "Nature", "DOI": "10.1038/359843a0", "doi-asserted-by": "crossref"}, {"key": "CIT0040", "author": "Steel G.G.", "volume": "56", "first-page": "525", "year": "1989", "journal-title": "International Journal of Radiation Biology", "DOI": "10.1080/09553008914551691", "doi-asserted-by": "crossref"}, {"key": "CIT0041", "author": "Stratford I.J.", "volume": "35", "first-page": "105", "year": "1986", "journal-title": "Biochemical Pharmacology", "DOI": "10.1016/0006-2952(86)90566-6", "doi-asserted-by": "crossref"}, {"key": "CIT0042", "author": "Tannock I.", "volume": "42", "first-page": "245", "year": "1981", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1981.37", "doi-asserted-by": "crossref"}, {"key": "CIT0043", "author": "Trotter M.J.", "volume": "59", "first-page": "706", "year": "1989", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1989.148", "doi-asserted-by": "crossref"}, {"key": "CIT0044", "author": "Vaupel P.", "volume": "51", "first-page": "3316", "year": "1991", "journal-title": "Cancer Research"}, {"key": "CIT0045", "author": "Weichselbaum R.R.", "volume": "19", "first-page": "313", "year": "1990", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(90)90539-V", "doi-asserted-by": "crossref"}, {"key": "CIT0046", "author": "West C.M.L.", "volume": "56", "first-page": "761", "year": "1989", "journal-title": "International Journal of Radiation Biology", "DOI": "10.1080/09553008914552011", "doi-asserted-by": "crossref"}, {"key": "CIT0047", "author": "Zeman E.M.", "volume": "12", "first-page": "1239", "year": "1986", "journal-title": "International Journal of Radiation Oncology, Biology and Physics", "DOI": "10.1016/0360-3016(86)90267-1", "doi-asserted-by": "crossref"}], "container-title": ["International Journal of Radiation Biology"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/09553009414550131", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 17]], "date-time": "2017-06-17T19:57:14Z", "timestamp": 1497729434000}, "score": 20.689106, "issued": {"date-parts": [[1994, 1]]}, "references-count": 46, "journal-issue": {"published-online": {"date-parts": [[2009, 7, 3]]}, "published-print": {"date-parts": [[1994, 1]]}, "issue": "1"}, "alternative-id": ["10.1080/09553009414550131"], "URL": "http://dx.doi.org/10.1080/09553009414550131", "relation": {"cites": []}, "ISSN": ["0955-3002", "1362-3095"], "issn-type": [{"value": "0955-3002", "type": "print"}, {"value": "1362-3095", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T15:39:39Z", "timestamp": 1575214779207}, "reference-count": 0, "publisher": "American Physiological Society", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Physiology"], "published-print": {"date-parts": [[1995, 12, 1]]}, "abstract": "<jats:p> Studies involving recordings of gross muscle blood flow and intravital microscopy have been used to analyze the behavior of muscle vasculature during systemic hypoxia. The roles of sympathetic nerve activity, circulating hormones (e.g., catecholamines, angiotensin, vasopressin), and locally released adenosine and K+ in determining the behavior of arterial and venous vessels are considered. </jats:p>", "DOI": "10.1152/physiologyonline.1995.10.6.274", "type": "journal-article", "created": {"date-parts": [[2017, 12, 24]], "date-time": "2017-12-24T15:26:22Z", "timestamp": 1514129182000}, "page": "274-280", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Skeletal Muscle Vasculature and Systemic Hypoxia"], "prefix": "10.1152", "volume": "10", "author": [{"given": "JM", "family": "Marshall", "sequence": "first", "affiliation": []}], "member": "24", "container-title": ["Physiology"], "language": "en", "link": [{"URL": "https://www.physiology.org/doi/pdf/10.1152/physiologyonline.1995.10.6.274", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 9]], "date-time": "2019-09-09T01:09:06Z", "timestamp": 1567991346000}, "score": 20.653801, "issued": {"date-parts": [[1995, 12, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1995, 12, 1]]}, "issue": "6"}, "alternative-id": ["10.1152/physiologyonline.1995.10.6.274"], "URL": "http://dx.doi.org/10.1152/physiologyonline.1995.10.6.274", "ISSN": ["1548-9213", "1548-9221"], "issn-type": [{"value": "1548-9213", "type": "print"}, {"value": "1548-9221", "type": "electronic"}], "subject": ["Physiology"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}